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There is a significant clinical need for engineered bone graft substitutes that can 
quickly, effectively, and safely repair segmental bone defects.  One emerging field of 
interest involves the growth of engineered bone tissue in vitro within bioreactors, the 
most promising of which, are perfusion bioreactors.  Utilizing a tubular perfusion 
system bioreactor, which allows media to perfuse freely around alginate scaffolds 
laden with human mesenchymal stem cells, large-scale bone constructs can be created 
by simply aggregating these beads together in the desired shape.  However, these 
engineered constructs lack inherent vasculature and quickly develop a necrotic core, 
where no nutrient exchange occurs.  Through the use of 3D printed vascular 
structures, used in conjunction with a TPS bioreactor, cell viability after just one day 
of aggregation was found to increase by as much as 50 percent in the core of these 
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Chapter 1: Introduction 
 
Clinicians and researchers are investigating new methods for repairing bone 
defects to meet the high demand for bone repair in the clinic. Currently, bone trails 
only blood as the most transplanted tissue.
1
 Bone tissue defects are often attributed to 
elevated levels of stress associated with physical activity, obesity, and aging,
1
 leaving 
a large portion of the population at risk. Each year, approximately 185,000 limbs are 
amputated in the United States alone.
2
 Approximately 15 million bone fractures 
occurred worldwide in 2011, with nearly 10% resulting in nonunions.
1
 The Food and 
Drug Administration classifies a fracture which fails to heal after nine months without 
intervention as a non-healing (i.e. critical) nonunion break
3
. Commonly, these non-
unions exhibit a substantial displacement between the two fractured ends. This gap is 
said to be above the critical defect size if it is so large as to not allow for natural 
healing. Normally, bones broken with gaps below the critical defect size will fill the 
void naturally with proper non-surgical fixation (hard cast, splint, sling, etc.) of the 
fracture. 
Nonunion fractures take an extended or indefinite time to heal, while typical 
fractures heal within a few weeks.
4
 Bone grafts and bone tissue engineering (BTE) 
strategies attempt to accelerate the healing process. Nonunions that require surgery to 
insert support materials can be complicated by infection, rejection of the implant, and 
revision surgery.
4
 Therefore, it is important to optimize these strategies to reduce 
potential physical and economic effects of these complications. Conservatively, about 
10% of traumatic fractures result in a nonunion.
5
 In 2010, the CDC reported 342,030 
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hospitalizations in the United States due to extremity fractures with an average 
treatment cost of $34,016.
6
 In these cases, surgical intervention is often needed to 
fully heal the wound through the use of artificial supports and bone grafts. 
 Transplanted human tissues used for bone regeneration may be derived from 
autologous sources (elsewhere in the patient’s body) or donated allogeneic tissue (e.g. 
cadaveric tissue, living donors). Approximately 1 million grafting procedures are 
performed each year.
7
 Autografts are the gold standard for harvesting bone tissue for 
implantation
3,8
 because autologous tissues have osteogenic (bone growing), 
osteoinductive (bone inducing), and osteoconductive (bone infiltration) properties.
3
 
Most commonly, surgeons remove a portion of the iliac crest and shape the explanted 
tissue for implantation elsewhere in the body.
3
 Regardless of harvesting site, 
introduction of a secondary defect site increases the risk for complications. This may 
include post-surgical pain, infection, and scarring at the donation site.
5
 Additionally, 
autografts are not possible for all patients and the maximum donation size is limited. 
The elderly, young, and sick may not be able to donate their own bone tissue for 
reimplantation, and up to 20% of patients experience complications from the 
harvesting procedure.
8
 Surgeons may also choose to inject the space with bone 
marrow, which has been shown to exhibit the necessary osteogenic and 
osteoinductive properties, but the clinical success of this has been limited and is 
insufficient for defects which require structural support.
3
 
Cadaveric donors overcome one limitation of autologous transplants – 
constrained supply – by providing allogeneic bone structures capable of bearing load 
without the restrictions of donor site morbidity. Allografts are the most widely 
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available option for treating long bone defects.
8
 Fresh allografts are rarely used due to 
the potential for serious infections such as HIV and Hepatitis C and the presence of 
immunogenic factors.
8
 Therefore, allogeneic bone requires processing prior to 
transplantation to reduce the risk of disease transmission, which also decreases the 
desirable biological activity of the tissue.
8
 Specifically, allografts have lower 
osteoinductive signaling relative to autografts and lack osteogenic signaling, resulting 
in slower growth of new bone.
1
 Still, the greater quantity of bone tissue available to 
surgeons allows them to pack allografts at higher density and promote 
osteoconduction.
3
 Even with the extensive processing, it is still possible for the 
transplant to be rejected.
1
 Substitute materials can be engineered with highly 
reproducible and tunable properties, which make them a desirable substitute for bone 
tissue derived grafts. 
Current clinical practices to heal long bone non-union defects primarily 
employ the Masquelet and Ilizarov techniques.
9
 The Masquelet technique involves 
the use of a temporary inert spacer to create and sustain a defined space in the bone, 
allowing a specialized membrane to form.
10,11
 After 4-12 weeks, the spacer is 
removed and the defect site is packed with autologous bone and allogeneic bone 
chips, with mechanical support provided by metal surgical hardware.
11
 The Ilizarov 
technique involves external fixation of the defect site, mechanically separated over 
time to allow for distraction osteogenesis.
12
 The main goal behind distraction 
osteogenesis is to continually extend the external fixation device as the bone heals, 
keeping the gap between the two fractured ends just below the critical defect size, 
thus allowing for natural healing over an extended period of time. This process results 
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in maximum healing rates on the order of 1mm per day, requiring the bulky external 
fixator to be worn for several months at a time.
13
 Both the Masquelet and Ilizarov 
techniques are complicated by substantial healing times and multiple surgeries,
11
 and 
the risk of clinical failure due to infection and recurring injury
9,12
. 
 Researchers are currently investigating in vitro strategies in an attempt to 
overcome the complications that arise as a result of the current clinical practices. 
Recently, research has shown much improvement in the field of bone tissue 
engineering that utilizes directed differentiation of stem cells to create osseous tissue 
constructs. A major complication of such constructs, however, is the lack of inherent 
vasculature. The research presented here demonstrates a novel, bottom-up approach 
to bone tissue engineering that lays out the foundation to create the first large-scale 
tissue constructs with inherent vasculature. Through the combination of a tubular 
perfusion system (TPS) bioreactor, computer aided design (CAD) and subsequent 3D 
printing and in silico modeling, we demonstrate the ability to create viable tissue 
constructs on the order of 20 cm
3
.  To put this in perspective, a 2014 review of 
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Chapter 2: Review of Related Literature 
 
Introduction 
 Vascular networks are a key component of any biological system. In fact, cells 
within the human body are restricted to a distance of 100-200 µm from the nearest 
capillary.
15,16
 Despite the overwhelming presence of vascular networks within the 
body, vascularization of implantable bone grafts remains a major limitation. Vascular 
systems provide cells with oxygen and glucose transport necessary for respiration, as 
well as an efficient means of waste removal.
15,17,18
 The human body has demonstrated 
the ability for vascular tissues to spontaneously invade implanted tissue.
15,19
 
However, host vasculature invades from the outside of an implanted scaffold inward, 
and thus the time required to achieve sufficient vascularization depends on the 
thickness of the implant. Spontaneous vascular ingrowth has been measured on the 
order of a few hundred nanometers per day,
19
 thus requiring several weeks to 
vascularize even the smallest of constructs. During this time, implantable constructs 
quickly develop a necrotic core.
15,17,18,20
 Those cells that do not die experience 
extreme nutrient gradients, with cells on the periphery of the construct consuming 
much greater levels of nutrients than those cells embedded deeper within the core. 
The unequal metabolic rates cause cells to release different signals, thus resulting in 
non-uniform differentiation of stem cells in these constructs.
19
 
 The need to create inherent vasculature is clear, and there are many different 
vascularization techniques currently being developed. However, there are also many 
different cell culture and tissue engineering strategies used throughout research, and 
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many vascularization techniques are incompatible with certain tissue engineering 
strategies. Therefore, the first step in designing vasculature for bone tissue 
engineering is to determine which cell culture and construct formation strategy will 
work best for the intended application. The research presented here focuses primarily 
on the use of tubular perfusion system (TPS) bioreactors, and the vascularization 
techniques were therefore tuned for use within these systems. 
TPS Bioreactors 
Bioreactor Design 
There are many different types of bioreactors currently being used in the field 
of bone tissue engineering (BTE) including spinner flasks, rotating wall systems, and 
perfusion systems. Though there are many different systems, they all seek to control 
the mechanical stimuli, and thus downstream pathways, on cells, as well as to 
regulate the cell culture media.
21
 Regulation of media helps provide adequate levels 
of nutrients and waste exchange to all cells uniformly, whereas mechanical stimuli 
primarily focuses on shear stress derived from the flow of media over the parts of the 
scaffold exposed to flow. In the body, bone reacts to, and remodels in the presence of, 
mechanical stimuli, as evidenced by the increased healing rates of bone in response to 
ultrasonic waves
22
. In in vitro environments, it has been hypothesized that shear 
stresses provide the bulk of this mechanical stimuli. Further, shear stresses on the 
order of 0.01 to 20 dyn/cm
2 
have been shown to impact both stem cell differentiation 
and mineralization.
23
 Therefore, many BTE bioreactor systems seek to expose human 
mesenchymal stem cells (hMSCs) to these levels of shear stress, in an attempt to 
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preferentially differentiate these cells down osteogenic lineages, as opposed to 
chondrogenic or adipogenic pathways. 
While all of the previously mentioned methods of dynamic culture have 
shown benefits over traditional static culture, success has been modest in spinner 
flask and rotating wall bioreactors, due to the less-ordered nature of the systems.
21
 At 
its most basic form, as spinner flask bioreactor simply consists of a BTE scaffold 
submerged in a flask containing cell culture media. Mechanical stimuli and flow of 
media is then provided via convection created by the spinning of a stir bar at the base 
of the beaker. Similarly, a rotating wall bioreactor contains a BTE scaffold in a flask 
consisting of two concentric cylinders. Here, the flow of media is driven through the 
viscous effects of media in contact with the both the stationary inner wall, and the 
rotating outer wall. In both of these systems, convection of media is relegated to the 
periphery of the constructs, and, while advantageous as compared to static culture, 
they still require small-scale constructs to allow for full diffusion of the necessary 
nutrients to the core of these constructs.
21
 In fact, cell death is often observed in the 
core of scaffolds as close as 200 µm from the scaffold surface.
24
 
Perfusion bioreactors overcome many of the limitations of spinner flask and 
rotating wall bioreactors, but require a significantly more complex setup. A typical 
perfusion bioreactor is composed of a media flask, which feeds into a custom-fit 
reaction chamber, via a tubing circuit. The media is then perfused through a porous 
BTE construct through the use of a pump. These systems have demonstrated 
increased proliferation, osteogenesis, and chondrogenesis of stem cells as compared 
to static culture and other dynamic culture options.
21
 However, in order to ensure that 
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media perfusion actually occurs through the pores of the BTE construct, the scaffold 
must be press fit into a custom sized reaction chamber to eliminate any void space 
between the scaffold and the chamber walls. The inherent porosity of the scaffold 
further limits the effect of perfusion bioreactors. Conventional scaffold fabrication 
techniques including gas-foaming, particulate leaching, and freeze drying often result 
in highly porous scaffolds. However, due to the random nature of pore orientation in 
these scaffolds, pore interconnectivity typically limits the flow of nutrients.
19
 To 
overcome these limitations, a system is needed that can provide for increased 
perfusion of nutrients and increased shear stresses, while eliminating of the need for 
custom fit reaction chambers. 
Advantages of a TPS Bioreactor 
Tubular perfusion system (TPS) bioreactors overcome all three of these 
limitations through a unique design. In a TPS bioreactor, a single scaffold is replaced 
by several modular units, which remain separate entities during the initial growth and 
differentiation period. When the researcher is satisfied with the state of the cells 
within these modular units, they can be easily aggregated to create a single BTE 
construct.
25
 Under the TPS design, these modular units are composed of alginate, a 
natural anionic polysaccharide derived from brown algae, due to its ability to self-
assemble into spherical beads. Further, cells can be isolated as alginate is dissolved in 
the presence of a chelating agent.  
Alginate consists of mannuronic and guluronic acid side chains.
26
 Alginate 
assembles into the “egg-box” model in the presence of divalent cations, such as Ca
2+
, 
due to the crosslinking of alginate chains driven by ionic interactions.
27
 This allows 
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for cellular encapsulation within alginate beads. When a cell population that is 
homogenous within liquid alginate is exposed to divalent cations, typically calcium in 
the form of a liquid CaCl2 solution,
26
 the alginate spontaneously forms alginate gel. 
This allows for the encapsulation of cells within the gel. By exposing the alginate to 
calcium solution dropwise, spherical gel beads are formed, with bead diameter largely 
a function of needle size.
26
 
Individual cell-encapsulating alginate beads are then loaded into a reaction 
chamber that consists simply of a tube capped by connectors of size such that 
perfusion of media is allowed without allowing beads to escape from the chamber. By 
dividing one larger scaffold into several smaller, spherical, modular units, perfusion 
of media easily occurs in the void space between the beads. This additional perfusion 
serves a two-fold purpose. First, under this model each individual bead sees direct 
convection over its outer surface. This allows for dramatically increased transport of 
nutrients.
28
 Alginate, while highly porous (~96%)
29
 is not particularly permeable, 






 This means that transport occurs 
primarily via diffusion. However, under this model, each individual bead represents a 
BTE scaffold. At the size scale of individual beads, nutrient transfer via diffusion is 
sufficient to maintain viability in each bead.
25
 The second benefit is increased shear 
stress throughout the scaffold. By utilizing a number of modular units, the surface 
area is greatly increased as compared to a single scaffold of the same overall size. As 
previously mentioned, flow through the interior of beads will be minimal due to its 
extremely low Darcy permeability, however, cellular differentiation and 
mineralization within TPS alginate beads have been shown to increase with 
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increasing flow rate and viscosity, both of which increase shear stress, as evidenced 
by Equation 1. Where µ is the dynamic viscosity of the fluid and u is the fluid 
velocity. The effect of increased shear stress on the periphery of each bead is thought 







                                                                 (1) 
After the growth and differentiation phase, individual beads are aggregated by 
simply filling the void space between beads with liquid alginate and then cross-
linking this liquid alginate with CaCl2 solution.
26
 After sufficient mineralization, the 
alginate can easily be dissolved through the addition of a chelating agent such as 




 Due to the bottom-
up design of the TPS bioreactor, construct size is limited only by in vivo 
vascularization requirements.  
 
Tissue Engineering Strategies for Vascularized Constructs 
 All living cells require nutrients for sustained growth and viability. In the 
body, diffusion of oxygen is limited to only 100-200 µm.
15,16,19
 Despite recent 
advances in bone tissue engineering, this diffusion requirement has relegated 
clinically used implants to thin or avascular tissues which can be vascularized by 
spontaneous host-capillary invasion, such as skin and cartilage.
19
 To address the need 
for large-scale tissue constructs, several vascularization techniques are currently 
under investigation, both in vitro and in vivo.  
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 The most common component of engineered vascular constructs is the 
presence of endothelial cells
33–36
. These cells are a major component of native 
vascular tissues, and form a confluent monolayer which line vascular networks 
providing an effective barrier to prevent hemorrhage while allowing for nutrient 
exchange. Briefly, vascular networks are formed via a three-phase process. First, 
endothelial progenitor cells (EPCs) differentiate and proliferate to form the early 
stages of a capillary network. After this phase, which is also known as 
vasculogenesis, angiogenesis occurs. During this phase, endothelial cells release 
matrix metalloproteinases (MMPs) which serve to degrade the extracellular matrices 
(ECMs) surrounding the primitive networks formed during vasculogenesis. As the 
ECM degrades, proliferating endothelial cells migrate into the void, remodeling and 
elongating the network to form blood vessels. Finally, these blood vessels are 




 For thin constructs, there is little need for a vascular network prior to 
implantation. Hypoxic conditions within constructs trigger the release of angiogenic 
growth factors, and this, combined with the host inflammatory response, triggers 
spontaneous host-capillary invasion which provides sufficient vascularization for thin 
grafts, such as skin.
19
 Current vascularization strategies are being used in conjunction 
with this natural response in an attempt to provide sufficiently perfused vascular 
constructs. 
 One such technique, termed in vivo prevascularization, provides implants with 
a vascular network that spans the major axis of a construct. This allows for direct 
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microsurgical anastomosis of the construct to host vasculature, and thus immediate 
perfusion of the construct. However, this technique requires that a host undergo two 
separate surgeries. First, the BTE construct is implanted into a healthy region of the 
body with a major artery. Over a time span of several weeks, the graft and the axial 
vasculature of the artery merge, and once the vascular axis within the graft is 
sufficient, it is removed from the implant growth site and inserted into the defect 
site.
19
 While this technique overcomes many of the major limitations of 
vascularization within BTE constructs, the requirement of two surgeries, as well as 
the removal of a major vascular axis from the initial implant site are significant 
drawbacks. In particular, the requirement for an axial vascular network to be removed 
from the initial implant site places limitations on the size of the implant, because as 
construct size increases, the removal of the initial implant becomes more dangerous. 
 Another promising approach utilizes in vitro prevascularization. Under the 
right conditions, EPCs can be directed to differentiate into endothelial cells and form 
vascular networks. Several design strategies include the addition of growth factors 
such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor 
(bFGF), platelet-derived growth factor (PDGF), and transforming growth factor β 
(TGF- β), among others, to stimulate the formation and remodeling of vascular 
networks. However, adding in too much of a growth factor can cause issues which 
include hemorrhagic vessels, and undesirable differentiation of seeded cells.
19
 While 
these strategies result in spontaneous, random microvascularization of constructs they 
are not sufficient as standalone techniques for complete vascularization of large scale 
 13 
 
constructs. Therefore, both in vitro and in vivo prevascularization techniques are often 
combined with other scaffold-based techniques. 
 Scaffold-based BTE must be carefully tuned to optimize construct 
survivability and functionality. Specifically, scaffolds must be significantly porous to 
allow for the migration of endothelial cells necessary to form vascular networks.
37
 
One significant challenge to scaffold-based vascularization is the difficulty of 
creating interconnected pores. In many systems, a high porosity is not enough to 
ensure pore interconnectivity.
19
 Furthermore, as porosity increases, scaffold 
mechanical properties and integrity decrease, reducing the capability for use in load-
bearing defects. There are many ways to create porosity within scaffolds. Particulate 
leaching involves the dispersion of a particle within a polymer resin. The polymer is 
then solidified, resulting in a scaffold with solid particulates randomly dispersed 
throughout. The scaffold is then exposed to a solvent that will dissolve the particulate, 
but not the scaffold.
37–39
 However, due to the random distribution of particulates, 
pores are rarely interconnected. This results in reduced cellular migration, but also 
residual particles, which raise cytotoxicity concerns. Another popular technique is 
freeze-drying
40
, or lyophilization. Under this system, hydrogels are rapidly cooled, 
causing phase separation. After sublimation of the solvent under a vacuum, void 
spaces left in the hydrogel act as pores.
37
 This method results in many of the same 
challenges caused by particulate leaching, specifically, a lack of pore 
interconnectivity. A third technique that results in a similar porous architecture is gas 
foaming. Under this method gas bubbles are formed either through a chemical 
reaction, or by placing the gas-saturated polymer in a high pressure environment. The 
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resulting bubbles displace the polymer scaffold, resulting in void spaces which form 
pores.
37
 Commonly, sodium bicarbonate is homogenized within the polymer resin, 
forming CO2 bubbles as it decomposes in the presence of an acidic environment 
induced after the polymer scaffold has been formed.
37
 When endothelial cells are 
introduced to scaffolds with sufficient pore interconnectivity, these techniques can 
result in randomly arranged microvasculature. However, without a major vascular 
axis, complete perfusion after implantation takes weeks.
19
 
 To combat many of the issues of these methods, 3D printing is often utilized. 
Here, there are two primary ways in which 3D printing techniques are used to create 
vasculature in BTE constructs. First, porosity and vascular channels can be created 
simply by utilizing printing techniques that leave user-defined voids for pores and 
vascular channels. The second method, which is also the method most commonly 
used, is sacrificial molding. This technique does not require that molds be 3D printed, 
but they often are, providing highly reproducible molds. 
 Several methods of 3D printing are used to create scaffolds with user-defined 
geometries and pore structures. These techniques largely serve the same purpose, 
with the major differences being the types of materials that can be used with each 
technique, and the resolution that each method offers. In the broadest sense, 3D 
printing can be broken down into two primary techniques, stereolithography and 
extrusion. Stereolithography involves the use of a liquid polymer resin and a light 
source. Here, the light source can either be visible light, or ultraviolet (UV) light, 
depending on the polymer. This technique requires that the polymer have side chains, 
such as methacrylate groups, which crosslink when exposed to a beam of light. Here, 
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highly focused light causes crosslinking of the photopolymer in a layer-by-layer 
fashion. Porosity can then be user defined either through the use of CAD files
41
, or by 
simply blocking the light path in certain areas, either by addition of particles in the 
resin, or by simply covering up portions of the glass through which the focused light 
passes.
20
 Major limitations of a stereolithographic approach include cell death caused 
by UV light, the requirement that polymers be photo-crosslinkable, and scaffold 
thickness limitations based on the max depth of light penetration.
20
 Major advantages 




 Extrusion based printing, which includes techniques such as fused deposition 
modeling (FDM) and fused filament fabrication (FFF), involves the layer-by-layer 
addition of material. Extrusion occurs either by drawing the material through a nozzle 
(FFF), or simply by applying pressure to force the material through a nozzle (FDM). 
Under an FDM system, the temperature of both the print head and build platform can 
be highly controlled to allow for multiple material types. Here, the polymer is placed 
at a temperature that allows for extrusion, while keeping it viscous enough to 
maintain strand integrity. By tuning the applied pressure and print head movement 
speed, strand diameter can be carefully controlled. Then, polymer fibers are deposited 
layer by layer onto a build plate, where the temperature is such that the resulting 
structure solidifies, with porosity controlled by adjusting strand diameter and spacing, 
as well as the angle at which each subsequent layer is applied. Under this system, UV 
crosslinkable photopolymers can also be used by simply curing each layer with UV 
light before the next layer is applied. While highly reproducible, this technique is 
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limited by a relatively large resolution, which is driven by the minimum strand 
diameter, a function of the print nozzle diameter. Further, this technique is limited by 
the strength of attachment of each layer to the next, as well as the imperfect alignment 
of each rounded strand to the rounded strand in the previous layer. 
 For these reasons, sacrificial molding is the most commonly utilized technique 
for creating vasculature in BTE constructs. Sacrificial molding involves the creation 
of a user-defined vascular mold. These molds can either be formed by printing a mold 
within a hydrogel to be filled with a sacrificial material, or by forming the scaffold 
around the sacrificial template. Major limitations of sacrificial molding include 
cytotoxicity of sacrificial materials
18
, and the challenges associated with creating 
relevantly sized, interconnected vascular channels. Further, sacrificial molding 
requires that scaffolds maintain their shape after the network material is sacrificed, 
which eliminates the possibility of using sacrificial molding within a TPS bioreactor. 
 Perhaps the most common method of creating sacrificial networks is solvent 
cast molding. Here, a soluble material such as poly(vinyl alcohol) (PVA),
18
 is poured 
into a mold with the desired shape. The cast is then allowed to solidify, and the tissue 
construct is built up around it. Once the construct is complete, the cast is sacrificed by 
simply exposing the construct to a solvent which will selectively dissolve the cast. 
Alternatively, certain cast materials can be sacrificed at elevated temperatures. These 
methods are limited by the properties of the sacrificial material, as they must be 
durable enough to withstand the process of generating the construct, while at the same 
be easily sacrificed under conditions that are not harmful to the construct or the cells 

















 Another way to create sacrificial channels within BTE constructs is through 
the incorporation of electrospun fibers. Electrospinning is the process of nanofiber 
formation driven by an electric current applied to a fluid jet composed of a polymer 
dissolved in a solvent.
49
 Electrospinning, commonly combined with a 
polydimethylsiloxane (PDMS) scaffold,
49
 allows for the formation of a complex 
nano-channel network. Electrospun fiber materials can then be sacrificed in a variety 




 fibers in water. 
Additionally, fibers formed by any number of other means can be encapsulated within 
a polymeric scaffold and sacrificed either manually
50
 (requires that channels not be 
interconnected), through the addition of a solvent, or by the application of heat
49
.  
 Despite the vast array of different vascularization strategies currently under 
investigation, relevantly sized BTE constructs remain largely avascular. Furthermore, 
the majority of the vascularization techniques produce vasculature on the micro-scale. 
However, the diameter of the human femoral artery ranges from about 6 mm to about 
10 mm,
51
 highlighting the need to create vasculature of much larger proportions. 
Therefore, a significant need exists to identify strategies that will allow for the 
vascularization of large-scale BTE constructs. Promising techniques involve a 
combination of multiple different strategies, along with the natural, spontaneous 
vascularization that occurs upon implantation. 
 18 
 
Oxygen in the hMSC Niche 
In vivo oxygen concentrations have long been known to influence cellular 
respiration, proliferation, and viability. Recent studies have examined the influence of 
oxygen concentrations on hMSC differentiation. Unfortunately, many of these studies 
yielded conflicting results, demonstrating the complexity of oxygen interactions in 
the body. It is, however, typically agreed that an increasing cell density results in a 
decreased specific oxygen consumption rate.
52
 Additionally, studies within cardiac 
tissue have shown that cell viability decreases linearly with oxygen concentration, 
while cell density decreases exponentially.
53
 These results were driven not only by 
decreasing viability with decreasing oxygen, but also decreased proliferation rates. As 
previously mentioned, capillaries provide the bulk of oxygen transport to cells, and it 
is for this reason that the maximum distance from each cell to the nearest capillary is 
typically limited to 200 µm.
15,16,54
 
Atmospheric air consists of 20.95% O2, or roughly 160 mm Hg
55
. By the time 
inhaled oxygen reaches arterial blood, these levels fall to about 7-12%,
56,57
 and fall to 
less than 5% in venous and capillary blood
56
. Further, interstitial oxygen levels within 
human tissues and organs range from around 2-9%,
55,56
 while average oxygen 
tensions within healthy bone marrow range from 6-7%
56–58
. Cells within BTE 
constructs under dynamic culture have been shown to live for up to seven days at 
oxygen levels just below 4%, whereas identical constructs under static culture yielded 
0% central oxygen concentrations in only five days, and marked cell death.
54
 
It is generally thought that low oxygen tensions (5%)  favor 
chondrogenesis,
53,55,59





. At the same time, long term exposure to oxygens tensions 
below 1% result in massive levels of cell death.
60
 Several studies have shown the 
inhibitory effects of low (2-3%) oxygen concentrations on both osteogenesis and 
chondrogenesis as compared to groups cultured at 21% oxygen.
59,61
 On the other 
hand, primary mouse osteoblasts cultured in 2% oxygen were shown to overexpress 
hypoxia-inducible factor α (HIFα), resulting in developed bone tissue that was much 
more dense and highly vascularized than cells that did not express HIFα.
62
  Similarly, 
an analysis on oxygen concentrations and the differentiation and proliferation of 
embryonic chick limb bud mesenchymal cells demonstrated an optimum oxygen 
concentration of 5%.
57
 It was further reported that rat MSCs cultivated in 5% oxygen 
yielded more bone mass than cells at 20% oxygen.
57
 Still, other studies have shown 
little difference in osteogenic differentiation in cells cultured in 2% oxygen as 
compared to cells cultured in 21% oxygen.
63
 This study did, however, demonstrate 
the inhibitory effects of oxygen concentrations below .02%. Furthermore, temporarily 
induced hypoxia (less than 4% O2) has been shown to upregulate VEGF expression in 
MSCs as the cells attempt to develop vasculature to relieve their hypoxic state.
60
 
These conflicting results demonstrate the complex nature of the oxygen-
hMSC interaction. This broad spectrum of results is hypothesized to be a result of the 
wide range of cell types, lines, and culture techniques used in these studies. With no 
clear choice of optimal oxygen concentration, the best method is to ensure that 









 With nearly 15 million bone fractures
1
 and 1 million bone grafting 
procedures
64
 worldwide, and 185,000 limb amputations in the United States each 
year
2
, there is a large clinical need for relevantly sized tissue engineered alternatives.  
Conventional techniques have so far been limited to tissue engineered constructs of 
less than 11 cubic centimeters,
14
 or about the size of an adult human pinky. Current 
research is limited by the need to embed large scale BTE constructs with the 
necessary vasculature for long-term graft functionality.  
The TPS bioreactor provides many advantages over both traditional static 
culture and the many different means of dynamic culture. Under the TPS model, 
increased proliferation, differentiation, and mineralization have been observed.
25,32
 
Furthermore, due to the bottom-up approach utilized by the TPS model, there is no 
limit on maximum construct size. Rather, the only limitation is the lack of a sufficient 
vascular network. Due to the unique nature of TPS bioreactors, many conventional 
methods of creating vasculature, notably sacrificial molding and scaffold-based 
design, are not applicable. Therefore, a novel approach must be utilized. Here, a 
biomimetic vascular network was created using stereolithography 3D printing in 
conjunction with the TPS bioreactor. Previously, constructs designed in the TPS 
model suffered the same diffusion limitations as traditional methods, and developed 
necrotic cores when grown to clinically relevant sizes. By incorporating a rigid 
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vascular structure, aggregated alginate constructs were successfully re-inserted to a 
TPS bioreactor. Due to the presence of a major vascular axis and a highly porous 
branched network that minimized the distance of each cell from the nearest nutrient 
source, aggregated constructs on the order of 20 cm
3
 were observed to be viable after 
24 hours. 
 
Materials and Methods 
SolidWorks Geometry Generation 
The use of stereolithography and other 3D printing techniques are 
advantageous not only because of the high degree of accuracy that they produce, but 
also because they allow any lab to reproduce the results of another, as long as they 
have access to the same computer-aided design (CAD) files. However, the CAD files 
must first be developed. Here, SolidWorks was utilized to create all structures to be 
printed. First, concept drawings were created that began and ended with a single inlet 
and outlet, respectively. This would allow for easy, direct anastomosis to existing 
host vasculature. In between the inlet and outlet, a series of branching is necessary to 
ensure that diffusion limitations are overcome. Final network design consisted of 
three vertical branches, each of which split into three more horizontal branches, for a 
total of nine branches. This system allowed for the greatest degree of symmetry, 
which would help to ensure uniform viability and differentiation. Ultimately, the 
center-most branch was removed, as it provided a direct path for fluid flow, and thus 
prevented flow from being evenly distributed throughout all of the other branches. 
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This change also served to free up space in the interior of the network to allow for a 
greater number of alginate beads to be encapsulated within the design. 
 Bioreactor tubing was chosen to be ¾” inner diameter (ID), and this, 
combined with the 3.5 mm diameter of the alginate beads (Appendix A, determined 
via a microscopic pixel count analysis), was the driving force behind the overall 
geometry of the network. The outer diameter (OD) of the inlet and outlet branches 
was chosen to be 3.0 mm. This choice served a two-fold purpose. First, it allowed for 
the connection of the 1/8” tubing that would supply the flow of media, and second, 
this size would allow for the anastomosis to relevantly sized host vasculature. The 
overall length of the network was limited by the length of the printer build platform, 
or approximately 70 mm. Once all of the design parameters were known, the actual 
CAD model could be developed, as seen in Figure 1.  
 
Figure 1: SolidWorks Design 
 To achieve the highest degree of symmetry, one quarter of the network was 
built, and then mirrored about two axes to create one whole network. First, a line 
diagram of the quarter network was drawn using the 3D sketch tool in SolidWorks. 
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Each horizontal branch was designed to be 22.5º from the center branch, and each 
vertical branch was 6 mm from the centerline (50º vertical branch angle). As 
previously mentioned, inlet and outlet channels featured 3 mm outer diameters to 
allow for connection to bioreactor tubing. After branching, the eight interior branches 
featured 2.4 mm outer diameters. These diameters, combined with the 6 mm vertical 
spacing between vertical branches, left 3.6 mm of void space, which is just enough to 
allow for the 3.5 mm alginate beads to infiltrate the network. The 22.5º horizontal 
offsets were also chosen to allow the beads to fill in the void spaces. Individual 
branches were formed by executing a surface loft of individual circles following the 
profile designed in the 3D sketch tool. Branches were then given thickness using the 
“thicken” tool. A thickness of 400µm was utilized to ensure printability (200µm wall 
thickness resulted in branch separation during printing). Internal horizontal and 
vertical bifurcation and trifurcation aids were created to allow for uniform flow 
through each branch, as seen in Figure 2. 
 
Figure 2: Network Design 
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 Pores were added to each branch using the simple, 2D “Boss/Extrude” tool. 
Using this tool, pore diameter and spacing could be readily tuned. Pores of 500, 750, 
and 1000 µm were printed. Ultimately, 750 µm pores were chosen, as this gave the 
best pore size to network integrity ratio (user preference based on print post-
processing skill).  Pore spacing, a user-defined variable, was determined through 
COMSOL simulations. The bead stop disk was also created using the “Boss/Extrude” 
tool. This bead stop was designed to prevent unnecessary bead waste that was 
observed between the tubing connectors and the start of the vascular network. 
 Custom designed connectors (Figure 3) were also needed to allow for the 
system to be housed within the 3/4" tubing, while at the same time allowing for the 
connection of 1/8” tubing to the actual network design.  These custom connectors 
feature a 1/4” OD channel which allows for easy external connection to bioreactor 
tubing. This then expands to 3/4" to provide an adequate seal which prevents the 
leakage of media from the reaction chamber. The connectors then feature a 1/8” OD 
channel for connection to the perfusion network. 
 
Figure 3: Custom Designed Connector – Units Displayed in mm 
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 Connectors to be used at the inlet featured a solid exterior, whereas outlet 
connectors featured the same overall geometry, but contained pores in line with the 
outlet flow (Figure 3) to prevent media stagnation at the outlet. 
 The final combination of connectors and the perfusion network resulted in a 
system that allowed for the direct perfusion of media throughout the interior of the 
designed network (Figure 4). The network was then surrounded by hundreds of 
alginate beads which filled the void space left not only between the outer edges of the 
network and the reaction chamber tubing, but also the void space between the exterior 
of adjacent horizontal and vertical channels. 
 
Figure 4: Bioreactor Network Design 
COMSOL Mass Transport Analysis 
 COMSOL is a commercial multiphysics software that utilizes finite element 
analysis to solve complex transient and steady state equations. As the porosity within 
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the designed perfusion network increases, so does mass transport of oxygen, waste, 
and essential nutrients, due to the increased surface area of alginate exposed to media.  
However, porosity and mechanical integrity are inversely proportional, and therefore, 
a mass transport analysis is necessary to determine the optimal porosity. It was 
hypothesized that an increase in porosity and a decrease in the distance from each 
bead to the nearest pore would result in increased oxygen concentrations throughout 
the BTE constructs. This hypothesis was tested through a wide array of COMSOL 
models. Here, the diffusion of oxygen throughout the construct was modeled in 2D 
using COMSOL’s “Chemical Species Transport, Transport of Diluted Species” 
module. The effects of convection and diffusion on pre-aggregation “free” beads have 
previously been shown to provide necessary levels of oxygen to encapsulated 
cells.
25,28
 For this reason, these COMSOL studies focused on convection and 
diffusion throughout the aggregated construct. Furthermore, alginate, while highly 






). The relationship between flow 







                                                             (2)  
Where Q is the flow rate, µ the dynamic viscosity of the media (0.78 centipoise)
25
, L 
is the length, and ΔP is the pressure drop. Previously, flow rate through a single bead 




 Based on this minimal flow rate, and taking 
into consideration both the free flow path that the printed network allows the media 
and the complete size of the alginate construct, convection through the aggregated 
construct was neglected. COMSOL convection and diffusion equations (Equation 3), 
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based on Fick’s Law, are therefore simplified, as the fluid velocity, u, is assumed to 
be zero. 
𝑁𝑖 =  −𝐷𝑖Δ𝐶𝑖 + 𝐶𝑖𝑢                                                   (3) 
Where Ni is the flux (mol/m
2
-s) through material “i”, Di is the diffusivity of material 
“i”, and Ci is the concentration of the diffusing species within material “i”.  
 Due to the presence of metabolically active cells within each alginate bead, a 
nutrient sink exists within the model. This sink is modeled through Equations 4 and 5, 
where Equation 4 is the Michaelis-Menten reaction kinetics equation, and Equation 5 




                                                (4) 
Δ(−𝐷𝑖Δ𝐶𝑖) + 𝑢Δ𝐶𝑖 = 𝑅𝑖                                           (5) 
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, and KMM is the Michaelis-Menten 




. It is important to note that the user must define 
R as a negative value, since it represents a consumption rate. It is also worth noting 
that, while the entire space confined between the tubing and the network should be 
modeled as alginate, only the beads themselves should be modeled as metabolically 
active. Converting the oxygen consumption rate to relevant units yielded a 




-s. For this analysis, networks that yielded 
oxygen concentrations below .04 mM (4% O2) were considered to be non-functional. 
This number was selected based on the concentration of oxygen in human capillary 
blood (~5%),
56
 in human tissues/organs (~2%-9%),
55,56
 and in bone marrow (~4%-
7%)
57
. While research has demonstrated conflicting information on the effect of low 
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oxygen tensions on MSC differentiation, and it is generally accepted that low oxygen 
tensions favor chondrogenesis to osteogenesis,
59
 the effect of these low oxygen 
concentrations on differentiation was not taken into account. This can be justified by 
the results of several experiments which demonstrate increased osteogenesis and 
proliferation
25,26,32
 pre-aggregation. Therefore, post aggregation oxygen 
concentrations need only support cell viability, as constructs will only be aggregated 
after significant differentiation and mineralization have occurred. 













 Media, which is contained in a flask constantly exposed to 
air and travels through 1/8” gas-permeable tubing, was assumed to be saturated water 
37 °C and 0.21 mol/m
3
, as calculated from Henry’s Law (Equation 6) and the Van’t 















)]                        (7) 
Where Caq is the concentration of oxygen dissolved in media, P is the partial pressure 
of oxygen in air, KH is the Henry’s Law constant, ΔH𝑠𝑜𝑙 is the enthalpy of dissolution, 
R is the universal gas constant, T
*
 is 298 K, and T is 310 K (37 ºC). All calculations 
can be found in Appendix B. Henry’s Law constants and enthalpy of dissolution 
values were obtained from the National Institute of Standards and Technology. 
 The air-saturation assumption further served to allow for the pores to be 
modeled by simply imposing constant surface oxygen concentrations of 0.21 mol/m
3
 
at each pore. Similarly, a constant surface concentration was imposed on the outer 
boundary of the reaction chamber tubing. The EShell network, was modeled as non-
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/s) to provide modeling for even the least permeable 
materials. 
 To mimic an in vivo environment, low-permeability fluorinated ethylene 
propylene (FEP) tubing was obtained (McMaster-Carr), in addition to the highly 
permeable silicone rubber (Cole-Parmer) tubing typically used with TPS bioreactors. 
Diffusivity values were converted (Appendix B) from permeability values given by 









/s for silicone.  
 Geometries were generated to represent 2D models of the printed network, as 
well as a single-channel design. This single channel was designed to mimic the worst 
case scenario of a TPS bioreactor with no vascular network. Due to the low 
permeability of alginate, a single tube must be created, even in this worst case 
scenario, or the back pressure will cause the tubing to explode. 
 Finally, the mesh settings were set to “Physics-controlled mesh” with 
individual mesh element size set to “normal”. These settings resulted in a total 
number of mesh elements on the order of 360,000 over an area of 1248 mm
2
.Visual 
inspection of these settings, as well as a comparison of results generated from 
differing mesh element sizes determined that these settings resulted in an acceptable 
degree of accuracy within a reasonable calculation time.  
SolidWorks Flow Analysis 
COMSOL helped to develop a keen understanding of the effects of porosity 
on diffusion, but a key phase of any TPS bioreactor is the pre-aggregation flow. In 
order to ensure uniform proliferation and differentiation, care should be taken to 
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ensure that flow profiles are roughly the same in all experimental groups. It was 
hypothesized that perfusion network design will have little effect on the pre-
aggregation viability of cells encapsulated within alginate beads, provided that each 
bead see some degree of convection. To test this hypotheses, 3 major groups were 
examined. First, the entire network was examined with a 1.5 mm center-center pore 
spacing. This distance represents the minimum pore spacing (maximum porosity) that 
can be achieved while still allowing for the user to be able to print and trim the 
networks. A full network with a 9 mm center-center distance was examined to gain an 
understanding of the effects of the minimum porosity, within reason, of a branched 
network on flow profiles. Finally, a single tube with pores every 9mm was created, 
once again to mimic the worst case scenario. It was also crucial to ensure that flow 
was uniformly distributed throughout each branch of the branched network. This was 
achieved by running several flow simulations and tweaking the size of the 
bifurcation/trifurcation aids until flow profiles were uniform. 
 Computational fluid dynamics (CFD) analyses could then be run utilizing the 
SolidWorks “Flow Simulation” add-in. SolidWorks develops accurate flow profiles 
by solving the Navier-Stokes equations for conservation of energy, mass, and 
momentum, using a finite volume analysis. A unique feature of CFD in SolidWorks is 
that it automatically determines the fluid volume, making it easy to set up. Further, 
because CAD models were originally designed in SolidWorks, there was no need to 
convert files or create entirely new files. However, SolidWorks CFD does require that 
all fluid volumes be fully constrained, so that the software can determine flow paths. 
Therefore, an outer shell of 3/4” ID was created using simple 2D extrusions. This 
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shell was made to be the same length as the network (67.72 mm), and was mated with 
the network in a SolidWorks assembly to fix their relative positions. Once mated, the 
network and the outer shell shared a longitudinal axis, as seen in Figure 4, and both 
parts inlets and outlets were aligned. Outer shell caps (3/4” diameter) were then 
created, once again using simple 2D extrusions. These caps were mated to the inlet 
and outlet ends of the outer shell, effectively containing the fluid volume. Finally, a 3 
mm diameter cap was created and mated to the face of the inlet to the perfusion 
network. This cap, though it overlapped with the inlet outer shell cap, served to allow 
the inlet flow to be constrained to only the network, as opposed to the entire outer 
shell.  
 Boundary conditions were then imposed, assuming fully developed flow. A 
flow rate of 450 mm
3
/s, or 27 mL/min, was imposed as the inlet boundary, and 
environmental pressure (1 atm) was imposed as the outlet boundary condition. This 
27 mL/min flow rate was determined based on an optimal flow rate of 3 mL/min that 
had previously been used in TPS bioreactor design.
25
 This 3 mL/min flow rate 
optimized the trade-off between shear stress and bead degradation. However, this 
flow rate was for a 1/4" ID system. Scaled to a 3/4" ID system, 27 mL/min achieves 
the same average fluid velocity (Appendix B). Furthermore, this flow rate is 
comparable to in vivo arterial flow rates.
65
 
 Finally, flow of media was modeled as water at 37 ºC, gravity was imposed to 
account for the vertical orientation of the reaction chamber within the incubator, and 
mesh resolution was set to “5”. This resolution value was determined to give the best 
results within a reasonable time. Even so, average calculation time was about 2 hours. 
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 After flow profiles of each group were observed, the flow of media through 
aggregated alginate was examined. An aggregated alginate construct was modeled by 
using the SolidWorks “mold” tool to create an exact mold of the network. To do this, 
all pores were first suppressed, and the network was cut in half along the longitudinal 
axis to allow for the use of “shut off surfaces” required by the mold tool. A half mold 
was created, and then mirrored about the cut plane to create a full mold. Then, the 
mold was mated with the flow assemblies created previously, carefully ensuring that 
all network pores were present once again. Using SolidWorks “porous media” 
module, an alginate material was defined using the Darcy permeability characteristics 
previously mentioned and added to the SolidWorks material library. This newly 
created material was then assigned to the mold. From here, all boundary conditions, 
media properties and resolution setup was the same as previously mentioned. 
Experimental Group Determination 
Taking into account the results of both the COMSOL aggregated diffusion studies 
and the SolidWorks pre-aggregation CFD studies, 5 experimental groups were 
determined to test the two-fold hypothesis. This hypothesis was that the perfusion 
network design will have no significant pre-aggregation impact on the viability of 
cells encapsulated within alginate beads, provided that each bead sees some degree of 
convection, while post-aggregation viability will be a function of oxygen 
concentration throughout the construct, and therefore porosity and distance of each 
bead from the nearest pore. First, a static control was utilized. This group featured 
cell-encapsulated alginate beads cultured in 6-well plates until Day 1, upon which 
they were aggregated and incubated in a 50 mL Falcon tube. This group is referred to 
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as “Static Control” in all relevant graphs and tables. All other groups were cultured in 
a TPS bioreactor. The second group featured a single channel with pores every 9 mm, 
once again to simulate the worst-case TPS scenario. This group is referred to as 
“Single Tube” in all relevant graphs and tables. A full network with pores every 9 
mm (referred to as “Distant Pore”) was utilized to validate COMSOL results as 
compared to a full network with pores every 1.5 mm (referred to as “Close Pore”). 
These three groups were cultured in FEP tubing to mimic the in vivo environment, 
where gas exchange on the periphery of these constructs would be limited. Finally, 
the fifth group featured a full network with pores every 1.5 mm housed in highly 
permeable platinum-cured silicone, to demonstrate the in vitro efficacy of these 
constructs. This group is simply referred to as “Silicone” in all relevant graphs and 
tables. The results of this group, in conjunction with the Close Pore group, would 
serve to demonstrate both elevated efficacy when culture in vitro, but also the 
feasibility to survive in an in vitro environment.  
3D Printing 
All 3D printing was completed using a Digital Light Processing (DLP) 
stereolithography printer (EnvsionTec). A clear polymer, EShell 300 (EnvisionTec) 
was chosen for both the perfusion network, and the connectors. EShell 300 is a clear, 
photocrosslinkable polymer, due to the functionalization of both acrylate and 
methacrylate groups. Tuned by the manufacturer for use with EnvionTec DLP 
printers, it provides resolutions on the order of 100-150µm, and is designed as a 
bioinert polymer for commercial hearing aid manufacturing.  
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First, CAD files of networks and connectors were imported as .stl files to 
Magics, an STL editor software. Parts were rotated and translated as necessary to 
align them to the build plate. They were then “fixed” using the built-in features of 
Magics to correct overlapping geometries, holes, etc. From here, support structures 
were generated within Magics. Support structures attach to the print files, and allow 
for rounded structures to adhere to the build platform, and ensure that separate 
branches and pores do not collapse onto each other during the build process. Part files 
and support structures were then imported to Perfactory RP (EnvisionTec), a software 
which allows the user to translate .stl files to the proper format to be used with 
Perfactory printers. Here, parts can be angled and rotated to allow for optimal use of 
build platform space. Additionally, build style is selected here. The EnvisionTec 
default build style for EShell 300 was used, with a step size of 50 µm.  
The Perfactory 4 (EnvisionTec) was the DLP printer utilized for all prints. 
Ensuring that the projector light type was set to “UV,” the intensity was calibrated to 
180 mW/dm
2
, as is recommended by the manufacturer. A 48-field calibration was 
used to achieve the highest degree of accuracy. Once calibrated, the flat calibration 
plate was exchanged in favor of the material tray, which features silicone rubber walls 
to allow for the containment of the liquid EShell 300 resin. From here, files were 
transferred to the printer, and the printer was left to run its course. The build plate was 
wide enough to allow for any combination of two separate files (two connectors, two 
networks, one connector and one network, etc.) to be printed at one time, as seen in 




Figure 5: Two Designs Printed Simultaneously 
 
Once the printer finished, the build platform was raised and prints were 
removed from the build platform using a putty knife. At this point, prints were soft-
cured, meaning that they maintained their shape, but were still very soft and sticky to 
the touch due to the presence of partially cured polymer. Prints were cleaned by 
spraying them gently with 99% isopropanol, and then placed into an isopropanol bath 
on a shaker platform for approximately 15 minutes. This cleaning process served to 
remove excess polymer, and ensure that pores and channels were not occluded.  
Following the cleaning process, parts were dried with compressed air, and 
support structures were trimmed using a razor blade and an X-ACTO knife. Parts 
were washed and dried again, and cured through the application of 4000 flashes in a 
light polymerization chamber (EnvisionTec). Remaining support structure debris was 
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then sanded down to yield smooth surfaces. Support structures can be seen in Figure 
6.  
 
Figure 6: Soft-Cured Network, Complete with Support Structures 
EShell Sterilization 
 EShell parts cannot be autoclaved, and were thus sterilized following a 
sterilization-rehydration protocol. First, five sterile beakers were sprayed with 70% 
ethanol and transported to a sterile hood. Similarly, an unopened 1 gallon jug of 
100% ethanol was sprayed into the hood, along with sterile phosphate-buffered saline 
(PBS, pH 7.4). The five beakers were filled with five different solutions (one each), 
of 100% PBS, 25%-75% ethanol-PBS, 50%-50% ethanol-PBS, 75%-25% ethanol-
PBS, and 100% ethanol. All parts to be sterilized were submerged in 100% ethanol 
and exposed to UV light for 15 minutes. Then, parts were gradually rehydrated in 
PBS by soaking them in increasing percentages of PBS, for five minutes per beaker, 
all while exposed to UV. Once the parts reached the final, 100% PBS, solution, they 
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were removed using sterile tweezers and stored submerged in PBS in sterile 50 mL 
Falcon tubes. 
Alginate Bead Formation 
Liquid alginate (2% w/v) was prepared by first creating a buffer solution of 
0.025M HEPES and 0.15M NaCl in Milli-Q water. The solution was then buffered to 
pH of 7.4. Alginic acid sodium salt (Sigma) was then added to a beaker containing 
the buffer solution to obtain 2% w/v. The alginic acid was dissolved into the solution 
through the use of a stir bar. At the same time, the entire system was heated to 60 ºC 
to aid in the dissolution of alginate. Clumps were broken up periodically using a 
laboratory spatula.  Once completely dissolved, the liquid alginate solution was 
autoclaved for 45 minutes on a liquid cycle. The autoclaved solution was then 
transferred into a sterile hood where it was filtered into 50 mL Falcon tubes using 3 
mL syringes to force alginate through .22 µm sterile filters. Sterile alginate was stored 
at 4 ºC until ready to use (maximum 5 days). 0.1M CaCl2 (Milli-Q water) solution 
was created, buffered to pH 7.4, and sterile filtered through a .22 µm filter.  
Human mesenchymal stem cell (hMSC) (RoosterBio) pellets were centrifuged 
at 200 x g for 10 minutes and resuspended in alginate at 37 ºC to achieve roughly 









                                       (8) 
A beaker was filled with approximately 10 mL of sterile CaCl2 for each mL of 
alginate. This solution was gently stirred using a stir bar. Following resuspension, 
cell-encapsulated beads were created by adding the cell-alginate solution to 0.1M 
CaCl2 dropwise using an 18 gauge needle from a height of about 6 inches above the 
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CaCl2 solution (Figure 7). This height allows for the formation of spherical beads 
(will be tear-drop shaped if dropped from too low due to the high viscosity of 
alginate). Beads were left to self-assemble for 15 minutes. Excess CaCl2 was drained, 
and beads were poured into the bioreactor reaction chamber by removing the outlet 
connector. The outlet connector was then reattached, and the system was tapped 
gently to allow the beads to settle and completely fill the void space between 
branches.  
 
Figure 7: Alginate Bead Formation 
Cell Culture 
3 million bone marrow-derived hMSCs (RoosterBio) were thawed and plated into a 
Corning 2-Stack (Sigma) according to RoosterBio Starter Kit Expansion Protocols. 
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Briefly, 1 vial of hBM-MSC Media Booster GTX was added to each 500 mL quantity 
of hBM-MSC Basal Medium (RoosterBio). This combination will henceforth be 
referred to as simply “high performance media.” The frozen cell vials (1 million cells 
each) were thawed in a 37 °C water bath until only a sliver of ice remained. The vials 
were sprayed with 70% ethanol and transferred into the hood, where cells were 
aseptically transferred into one 50 mL Falcon tube per vial. 4 mL of high 
performance media at room temperature were added dropwise to the cells in each 
tube. Cells were centrifuged at 200 x g for 10 minutes. The supernatant was removed 
and cells were resuspended in 45 mL each of high performance media. These cells 
were then seeded into the 2-Stack, and high performance media was added to bring 
the total volume to 250 mL. After four days, cells were washed with 50 mL sterile 
phosphate-buffered saline (PBS, pH 7.4). PBS was aspirated, and cells were lifted by 
adding 50 mL trypsin-EDTA (Fisher). Trypsin was quenched with and equal volume 
of PBS + 1% Fetal Bovine Serum (FBS, Fisher). The cell suspension was transferred 
into 50 mL Falcon tubes, and centrifuged at 200 x g for 10 minutes. Supernatant was 
aspirated, and the cell pellets were resuspended into 100 mL fresh high performance 
media. The cell suspension was then plated into a Corning 10-Stack (Sigma), and 
high performance media was added to bring the total volume to 1.5 liters.  
 After 4 more days, cell pellets were isolated following the same procedures as 
above, but requiring 250 mL each of PBS to wash, trypsin-EDTA to lift, and PBS + 
1% FBS to quench. Total cell count reached 400,000,000 (determined via a trypan 
blue exclusion assay). These cells were then suspended equally into 100 mL of 
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alginate, to achieve a seeding density of approximately 130,000 cells/bead (Equation 
8).  
 Perfusion and static culture media for use with encapsulated alginate beads 
was Dulbecco’s Modified Eagle Media plus 10% FBS, 1% antibiotic-antimycotic 1% 
non-essential amino acids and 2% L-glutamine (all components from Fisher).  
Bioreactor Setup 
A Masterflex L/S peristaltic pump (Cole-Parmer) drives the flow of media throughout 
the bioreactor. Masterflex two stop L/S 14 tubing is fed into the pump. All tubing and 
connectors were first autoclaved, with the exception of EShell parts, which were 
sterilized as described above. Using appropriate 1/8-1/8” connectors, 1/8” ID tubing 
extends from both ends of the pump tubing. As seen in Figure 8  (page 41), one end is 
fed into the media flask, which is stopped with a rubber stopper with two holes for 
tubing. The other end extends as necessary and is connected to a short (~ 2 in) section 
of ¼” ID tubing. This tubing feeds into the custom printed EShell connectors. A short 
(~ 2 cm) section of 1/8” tubing connects the EShell connectors to the printed network. 
A second, similarly sized section of 1/8” tubing is attached to the outlet connector. 
The ¾” reaction chamber tubing (FEP or platinum-cured silicone) is then slid over 
top of the inlet connector/printed network assembly. Alginate beads are then poured 
in from the top until they become level with the end of the outlet channel. Once this 
chamber has been filled with alginate beads, the outlet connector is carefully added 
such that the 1/8” tubing that was pre-assembled on the connector fits over the outlet 
of the printed network. Another 2 inch section of ¼” tubing is attached to the outer 
end of the outlet connector. This is then connected to a length of 1/8” tubing, which is 
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fed into the remaining slot in the flask stopper. All four bioreactor groups were run in 
parallel on the same pump (Figure 9). Once set up in a sterile hood, the entire system 
is then transported to a cell culture incubator at 37 ºC, with 5% CO2 where the 
reaction chamber is suspended vertically to allow for the removal of any air bubbles 
by gravity. Each experimental group had its own separate media flask, filled with 250 
mL of perfusion media as demonstrated by Figure 9, which features the complete 
setup installed into the incubator at 37 ºC. All groups saw a flow rate of 27 mL/min. 
 




Figure 9: Bioreactor Setup Featuring 4 Experimental Groups in Parallel 
Construct Aggregation 
Constructs were aggregated within the reaction chamber using a two-syringe method, 
similar to double-barrel syringe epoxy techniques. Here, two separate syringes were 
used due to space constrictions. First, the outlet connector was removed, exposing the 
alginate beads. Then, using a 10 mL syringe complete with 18 gauge needle, acellular 
alginate at 37 ºC is injected in increments of 10 mL by carefully sliding the needle 
down the void space between the inner chamber wall and the nearest bead. This liquid 
alginate is prepared and sterilized in the same manner as above. Following each 
alginate injection, 10 mL of 0.1M CaCl2 is carefully injected in a similar manner. 
Any excess CaCl2 that rises above the level of alginate beads is carefully aspirated. 
This technique is performed 3-5 times, allowing a 5 minute period for alginate gel 
formation in between each injection. After the final injection of alginate and CaCl2, 
the system was left to aggregate for 15 minutes. Once satisfied with the aggregation, 
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the outlet connector was reattached, and the entire system transported back to the 
incubator where it was perfused again. 
 The statically cultured beads were aggregated by placing a 3 inch section of 
platinum-cured silicone rubber tubing on a sterile surface. Statically cultured beads 
were then placed into this tubing. Once all of the beads had been placed, the construct 
was aggregated in the same manner as above. Once aggregate, the construct was 
placed into a 50 mL Falcon tube. The Falcon tube was then filled with media and 
placed into the incubator at 37 ºC. 
Viability Analysis 
Beads were harvested at each of six harvest sites for each experimental group. The six 
locations were named bottom inner, bottom outer, middle inner (core) middle outer, 
top inner, and top outer. Here bottom, middle, and top refer to vertical distance from 
the inlet, while inner and outer refer to radial distance from the centerline. 
Furthermore, in experimental groups featuring a full network, beads from the middle 
inner group were beads which filled the space in the dead center of the network. 






Figure 10: Harvest Sites 
In order to harvest beads from the bottom of the TPS groups, the network was 
physical pulled out of the reaction chamber. To preserve non-harvested bead 
locations, non-harvested beads were poured into a 50 mL Falcon tube as they were 
removed from the reaction chamber. Once harvesting was complete, they were 
reinserted to their proper location by simply inverting the Falcon tube over the 
reaction chamber. 
Each experimental group was assigned its own 6-well plate, and each well 
was labeled to allow for the proper segregation of beads from each harvest site. Three 
beads were harvested from each site at 24 hours (n=3). Because statically cultured 
beads were cultured in 6-well plates at Day 1, harvest sites did not apply. Therefore, 
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beads were chosen and analyzed at random (n=3). After this initial harvest, the 
constructs were aggregated. After 24 hours of aggregation (48 hours from experiment 
start), beads from each harvest site were once again harvested (n=3). At this time 
point, harvest sites did apply to the static culture, and were therefore taken into 
account. In addition to the six harvest sites, beads were harvested for dead controls 
from each group (n=3). Dead control beads were soaked in 70% methanol for 15 
minutes before aspirating the methanol.  
Beads were then immersed in a solution of 1mM calcein AM (CAM), 2mM 
ethidium homodimer-1 (EH) (Fisher) in PBS. 1.5 mL was applied per 6-well plate 
(.25 mL per harvest site). Beads were then left to sit in solution for 30 minutes before 
imaging with a fluorescent microscope. This entire process was performed in a dark 
environment due to the photosensitivity of the CAM/EH solution. 
Each bead was then imaged at both 2.5 x and 10 x magnifications. Live and 
dead images were saved to a computer and were then merged and counted using 
ImageJ software following the protocols in Appendix C. These protocols were written 
as macros, which not only saved time, but also ensured that each image was analyzed 
consistently. A few images, selected at random, were then counted by hand to verify 
the automated counting process. 
Results were saved to Excel (Appendix A) and imported to Minitab for 
analysis. Using an ANOVA (one-way analysis of variance) test, combined with 
Tukey’s test, statistical significance was determined. Results were then plotted, and 




Initial Bioreactor Setup 
The bioreactor was first set up using acellular beads in a non-sterile 
environment. The reaction chamber was loaded with beads, and it was observed that 
approximately 20-25 mL of alginate, or 600-750 beads, was required to fill each 
reaction chamber. Once the beads were loaded, the bioreactor was perfused with 
deionized water. Once fully perfused, a few drops of green food dye were added to 
the flask of water. It was observed that the green dye diffused throughout the reaction 
chamber, with the exception of the space between farthest interior edge of the inlet 
connector and the beginning of the perfusion network, as demonstrated by Figure 11. 
It was for this reason that the bead stop described above was added into the design. 
Final network design, complete with bead stop and pores, is shown in Figure 12.  
 






Figure 12: Final Network Design 
 Constructs were then aggregated 
according to the prescribed method. It 
was observed that approximately 20 mL 
of alginate was required to completely 
aggregate each construct. Following 
aggregation, as shown in Figure 13, 
constructs were reinserted to the 
bioreactor, and perfused again. This time, 
green dye was exchanged for pink, to 
allow for visual examination of dye 
diffusion. The construct was then 
perfused overnight. As illustrated by Figure 14, the dye diffused into the entire 
construct over a period of 24 hours. 




Figure 14: Rehydration of Aggregated Construct 
 
COMSOL Diffusion Studies 
COMSOL diffusion studies initially focused on the middle of the three 
vertical branches. That is, these studies first focused on the two channels that branch 
directly off of the inlet, and feature a large void space where the middle-most branch 
was removed. Due to the presence of the largest void space, this cross section has the 
largest chance to see the presence of dead cells. At the same time, due to the high 
degree of network symmetry about the longitudinal axis, it was determined to be 
redundant to model both horizontal and vertical cut planes.  
 Initially, the maximum porosity network, represented by a center-center pore 
distance of 1.5 mm was compared to the minimum (within reason) porosity network, 
represented by a 9 mm center-center pore spacing. These results, displayed in Figure 
15 and Figure 16, demonstrate a clear difference in oxygen concentrations between 
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these two groups. However, it is important to note that, when modeled with platinum-
cured silicone tubing as they are here, neither group falls below the 0.04 mM 
threshold at any point. In fact, the lowest value in the 9 mm spacing group is about 
7% oxygen. The nice thing here is that due to the value of the Henry’s Law constant 
at 37 ºC (959.3 L-atm/mol), concentration in millimolar is roughly equivalent to 
percent oxygen values (4% O2 = .0417 mM). It is also important to note that in all of 
the COMSOL images to be displayed, the scale on the x and y axes is in millimeters, 
and the rectangular nodes along the periphery of the channels represent the pores of 
the networks. In all images, red represents high oxygen concentrations, and blue 
represents low oxygen concentrations. 
 





Figure 16: 9mm Pore Spacing Oxygen Concentration - Middle Branch, Silicone 
 Due to the prevalence of suitable oxygen values throughout, the effect of 
using a less permeable tubing was examined. These Results are displayed in Figure 




Figure 17: 1.5mm Pore Spacing Oxygen Concentration - Middle Branch, FEP 
 
Figure 18: 9mm Pore Spacing Oxygen Concentration - Middle Branch, FEP 
As demonstrated here, in a simulated in vivo environment, oxygen concentration 
nears 0% in the 9 mm pore spacing group. 
 Oxygen concentration was then examined in the upper and lower branches. 
Because they are identical, one model worked for both branches. These groups were 
similarly run using both silicone and FEP tubing, but as before, the silicone tubing 
provided so much oxygen content that the entire system contained healthy levels of 
oxygen. Therefore, only the FEP results are displayed below. For all graphs, 




Figure 19: 1.5mm Pore Spacing Oxygen Concentration - Top/Bottom Branch, FEP 
 
Figure 20: 9mm Pore Spacing Oxygen Concentration - Top/Bottom Branch, FEP 
These models validate the assumption that middle branch analyses can serve to model 
oxygen concentrations in the interior due to their larger interior void space. Here, the 
exact same minimum oxygen concentrations are observed as in the corresponding 
middle group models. Once again, the 9 mm pore spacing concentration nears 0%. 
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 With the extremes of network porosity measured, the next series of models 
was undertaken to determine the minimum pore distance at which oxygen 
concentration remains above 4%.  
 
Figure 21: 3mm Pore Spacing Oxygen Concentration - Middle Branch, FEP 
 
Figure 22: 6mm Pore Spacing Oxygen Concentration - Middle Branch, FEP 
Figure 21 represents a 3 mm center-center pore spacing, while Figure 22 represents a 
6 mm center-center spacing. Here, oxygen concentration in the 6 mm model falls 
below 4% in areas where the distance from each bead to the nearest pore is at a 
 54 
 
maximum, whereas the 3 mm model maintains oxygen levels above 4% at all 
locations. Once again, top/bottom branch models can be found in Appendix E.  
 Finally, the effect of utilizing a single tube, once again representing that worst 
case TPS scenario, was examined. Here, Figure 23 represents a 1.5 mm pore spacing, 
and Figure 24 represents a 9 mm pore spacing. Figure 24 clearly demonstrates that a 
single tube with 9 mm pore spacing will not support cell viability. Interestingly, 
Figure 23 shows oxygen concentrations above 4% in nearly all regions. However, this 
can largely be attributed to Michaelis-Menten reaction kinetics, where metabolic 
activity is actually a function of oxygen concentration. Therefore, cells on the 
periphery of constructs would display lower metabolic rates, and thus differing 
differentiation and proliferation characteristics. 
 




Figure 24: 1.5mm Pore Spacing Oxygen Concentration - Single Tube, FEP 
SolidWorks CFD Analysis 
CFD results from SolidWorks flow simulations demonstrate flow velocities 
similar to average velocities in previous TPS bioreactor experiments.
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 Furthermore, 
flow profiles for all three groups examined were relatively consistent, with similar 
velocities throughout the design, and a uniform distribution of flow throughout all 
branches. 
 




Figure 26: Full Network, 9mm Pore Spacing CFD Results 
 
Figure 27: Single Tube, 9mm Pore Spacing CFD Results 
More images of these flow simulations can be found in Appendix F. 
 Finally, CFD results validate the assumption of zero convection within fully 
aggregated constructs, as demonstrated in Figure 28 and Figure 29, where the entire 




Figure 28: Flow Through an Aggregated Alginate Construct 
 
Figure 29: Containment of Flow Through an Aggregated Alginate Construct 
In Vitro BTE Construct Viability 
BTE construct viability was further examined in vitro through the use of viability 
assays after 24 hours of pre-aggregation flow (Day 1), and after 24 hours of post-aggregation 
flow (Day 2). Over 1,000 live/dead viability images were taken and processed to obtain 
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percent live cell counts. The percentage of live cells in each experimental group were not 
statistically different at the Day 1 time point, as evidenced by Figure 31. Graphs for each 
individual group can be found in Appendix D. 
 
Figure 30: Day 1 Merged Live/Dead Images 
 
Figure 31: Day 1 Percent Live Composite Averages 
  
Day 2 analyses displayed differing results, as expected. Figure 32 provides 
representative images of samples taken from the core of Static Control and Silicone 
experimental groups. These results are graphed in Figure 33, where groups that do not 





Figure 32: Viability in the Core of Static Control and Silicone Groups 
 
Figure 33: Graphical Representation of Core Viability 
It is worth noting that every group, with the exception of the Distant Pore group, is 
statistically different from the Static Control, with the Silicone group achieving an 
average of more than three times the percentage of live cells in static groups. 
 Figure 34 is a graphical representation of the composite averages of each 
harvest site. Graphs of the percentage of live cells for each harvest site can be found 




Figure 34: Day 2 Percent Live Composite Averages 
Discussion 
COMSOL Diffusion Studies 
By comparing each COMSOL diffusion model against all others, it was 
observed that the use of platinum cured silicone tubing for the reaction chamber 
caused the diffusion of oxygen from the periphery to dominate the diffusion of 
oxygen from the networks. This resulted in all groups achieving oxygen levels above 
the chosen floor of 4%. For this reason, FEP tubing was utilized to mimic an in vivo 
environment. Here, was hypothesis was that an increasing porosity, driven by a 
decreasing center-center pore distance, along with a decreasing distance from each 
bead to the nearest pore, as driven by the presence of a branching network, will 
increase oxygen levels throughout the scaffold. This hypothesis was validated 
through the many COMSOL studies. Further, it was shown that while a 1.5 mm pore 
spacing will achieve O2 levels above 4%, a 3 mm pore spacing will also achieve this 
same result. However, at a spacing of 6 mm O2 levels begin to fall below 4%, and at a 
spacing of 9 mm, a significant portion of the construct nears 0%. In single tube 
networks with pore spacings of 9 mm, the entire construct fell well below 4% O2. 
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Finally, it was shown that while a single tube with pores every 1.5 mm results in O2 
levels above 4% throughout the construct, this architecture results in significant 
gradients, where O2 levels drop as radial distance from the centerline increases. Due 
to the dependence of proliferation and differentiation on O2 concentration, this 
architecture would result in non-uniform differentiation, and likely non-functionality 
of the construct. Therefore, the developed construct must make an effort to equalize 
the distance of each bead to its nearest pore, a challenge which is best met through the 
use of a symmetric, branched network. 
SolidWorks CFD Analysis 
CFD analysis of three separate SolidWorks designs (branched network with 
1.5 mm pore spacing, branched network with 9 mm pore spacing, and single tube 
with 9 mm pore spacing) demonstrated similar flow profiles and velocities in all three 
groups. Furthermore, these velocities were on par with those shown to increase 
differentiation due to the application of shear stress in previous TPS experiments.
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 It 
was hypothesized that perfusion network design will have little effect on the pre-
aggregation viability of cells encapsulated within alginate beads, provided that each 
bead sees some degree of convection. The CFD simulations demonstrated an 
expected similarity of pre-aggregation flow, allowing for in vitro experiments to test 
this hypothesis. 
At the same time, CFD analysis of flow in an aggregated construct resulted in 
zero flow perfusing into the alginate, confirming results obtained from Darcy’s Law 
calculations. In in vitro experiments, small amounts of convection actually occurred 
throughout the constructs due to imperfect aggregation. It is hypothesized that this 
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extra post-aggregation convection attributed to elevated cell viability in Single Tube 
and Distant Pore groups. 
In Vitro Viability Analyses 
The in vitro analysis of hMSCs in our modified TPS bioreactor allowed for the 
testing of the overarching, two-part hypothesis. This hypothesis was that perfusion 
network design will have little effect on the pre-aggregation viability of cells 
encapsulated within alginate beads, provided that each bead sees some degree of 
convection, while post-aggregation viability will be a function of oxygen 
concentration throughout the construct, and therefore porosity and distance of each 
bead from the nearest pore. 
 Day 1 viability analyses at each harvest site yielded data that validated the 
first part of this hypothesis. In fact, Day 1 composite averages across all sites yielded 
no statistically different results. It should be noted here that Day 1 viability was 
roughly 60% across all groups. This viability was lower than expected, and can be 
attributed to the extended time that each harvested bead spent without nutrients before 
it was imaged. Normally, aggregation of each group would take less than 25 minutes, 
and with the alginate gels trapping many nutrients, cells would not experience a lack 
of nutrients during this time. However, due to the requirement to harvest beads from 
six sites from each of 4 groups, along with the need to aggregate and re-perfuse each 
construct, harvested beads sat without media for a period of about several hours. It is 
worth noting that care was preferentially given to beads within the constructs that 
would be re-perfused and examined at Day 2, as these results form the core of the 
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novelty of this research. Further, though harvested beads were removed from media 
for a significant period of time, this time was the same across all groups. 
 While important, pre-aggregation viability and flow profiles can actually be 
circumvented by simply running the bioreactor without the printed network, as has 
been proven to work in the past. Then, once cells within the beads begin to 
differentiate and calcify, they can be removed from the pre-aggregation chamber, and 
aggregated around a printed network for re-perfusion as was done here. However, it 
was necessary to examine the pre-aggregation viability of a network-containing 
bioreactor in order to accurately determine the causes of viability trends. 
Additionally, if pre-aggregation differentiation and mineralization in a network-
containing bioreactor are comparable to those without, much time and effort can be 
saved by simply utilizing a network from the beginning stages. 
It is also worth noting that while FEP tubing provided a significant barrier to 
O2 diffusion, it was very rigid and thus very hard to work with. Because of the 
stiffness of the tubing, significant force had to be applied to achieve a tight seal 
around the connectors. In fact, a silicone sealant and sealing tape had to be used to 
prevent leakage and the formation of air bubbles due to the presence of micro-cracks 
at the tubing-connector interface. For this reason, FEP tubing is not recommended, 
unless absolutely necessary, as it was here. These issues were not present in the 
Silicone group. The application of force necessary to achieve a tight seal caused the 
Single Tube design to snap in half. On top of its frailty, the Single Tube group failed 
to adequately bond with the aggregated construct, as shown in Figure 35, 
demonstrating the need for a box-like structure to maintain construct integrity. This 
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can be attributed to the hydrophilic nature of the alginate, as opposed to the 
hydrophobic nature of the EShell. The frailty and lack of construct integrity of the 
single tube design are just two more reason why a more robust structure is needed. 
 
 
On the other hand, full, branched network designs allowed for the formation 
of tight cylindrical constructs, with a single inlet and outlet that would allow for 
direct anastomosis to existing host vasculature, as shown in Figure 36.  
 
Figure 36: Aggregated Construct Demonstrates Possibility of Direct Anastomosis 
Figure 35: Failure of Single Tube to 




Day 2 viability results displayed a clear trend of decreasing viability with 
decreasing porosity, as evidenced by the Day 2 composite averages represented in 
Figure 37. In this figure, the COMSOL oxygen concentrations can be found directly 
above the corresponding in vitro results for each group. This trend validates the 
second part of the hypothesis that oxygen concentrations would decrease with 
decreasing porosity, and therefore a decrease in porosity would cause a decrease in 
viability. It is hypothesized that the Single Tube viability was unusually high because 
the tube snapped in half upon reattachment of the connectors post-aggregation. In 
order to connect this tubing to the outlet connector, construct height was also cut in 
half, resulting in a much lower diffusion distance than in other groups, as the top 
surface was exposed directly to media. 
 
Figure 37: Composite Averages and Corresponding COMSOL Expectations 
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Perhaps the most important Day 2 results are obtained from the Middle Inner 
(core) harvest sites (Figure 33, page 59). Here, the need for inherent vasculature is 
painfully obvious, with only about 20% of Static Control cells still living after just 24 
hours. At this harvest site, all groups were statistically different except for the Distant 
Pore group, but even that group had a mean percent live count of nearly double that in 
the Static Control.  
On the subject of the Static Control group, it is worth noting that it is not 
surprising that the percentage of live cells was often higher than in the Distant Pore 
and Single Tube groups at all harvest sites except for the core. This is because in the 
Static Control group, all harvest sites except for the middle inner site were directly on 
the periphery of the construct, and thus directly exposed to static media. On the other 
hand, the outer harvest sites in the bioreactor groups were adjacent to the tubing wall, 
and thus saw little direct exposure to media. It is for this reason that the Static Core 
viability is as high as it is in the composite average, and the Middle Inner results are 
so important. Further, as overall construct size increases, the surface area to volume 
ration will decrease. Therefore, a larger percentage of cells will be contained in the 
core than on the periphery. Similarly, as construct size increases, the time required for 
complete host-invasion vascularization increases, resulting in long term hypoxic 
conditions in the core region. Therefore, while the composite average is necessary to 
demonstrate cell viability at all construct locations, the Middle Inner, or core, harvest 
site is perhaps the most important, and contains the largest percentage of cells when 
dealing with large constructs. 
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 As for the viability in the Single Tube and Distant Pore groups, it is 
hypothesized that imperfect aggregation led to higher viability levels than expected 
from the COMSOL modeling, as some degree of convective flow was observed 
throughout these constructs. 
Future Directions 
The end goal of this work is to develop the capability to both create and 
replicate large scale bone tissue engineered constructs, complete with inherent 
vasculature ready for direct anastomosis to host vascular networks. While this work 
focuses primarily on TPS bioreactors, the application of the network design is not 
limited to this family of bioreactors. At its most base element, the designed network is 
simply a CAD file. How this file is utilized is completely determined by the 
researcher. Here, it was used to create a rigid structure that directly composes the 
vascular network for us in a TPS bioreactor. Similarly, constructs could be molded 
around this network to create structures more commonly used in direct perfusion, or 
even spinner or rotating wall bioreactors. Alternatively, the mold structure used in the 
CFD modeling could be printed, and used to cast a sacrificial vascular network, or the 
network could be directly printed with a sacrificial material. The potential for use in 
both of these methods of creating sacrificial vascular networks greatly increases the 
number of material types and fabrication techniques available to the researcher. The 
outer geometries of scaffolds created around this network could be tailored to fit any 
bioreactor type, and could be combined with other vascularization methods, such as 
particulate leaching, to achieve a system complete with both a direct vascular axis and 
a high degree of porosity to encourage vascular ingrowth and cell migration.  
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The next logical step in the progression of this work is to replace the bioinert, 
non-degrading EShell material with a non-cytotoxic biomaterial which will degrade 
over time, to be gradually replaced with host vasculature. Further, a co-culture of 
hMSCs with endothelial cells could allow for the creation of a confluent monolayer 
of endothelial cells on the inner surface of the printed network. Ideally, this 
monolayer of cells would then branch out of the network, via the network pores, 
allowing for vascularization of the construct not only from the outside-in via 
spontaneous host-capillary invasion, but also from the inside out. This would 
dramatically decrease the time necessary for complete construct vascularization. 
Conclusion 
With over 185,000 limb amputations in the United States alone,
2
 and 
approximately 15 million bone fractures worldwide every year,
1
 there is a large 
clinical need for bone tissue engineering alternatives. At present, approximately 1 
million grafting procedures are performed each year.
64
 Risk factors for bone injury 
include physical activity, obesity, and aging,
1
 meaning that nearly the entire 
population is at risk. While grafting procedures and surgical techniques help to heal 
bone defects, they leave many undesirable effects including infection, graft rejection, 
donor site morbidity, and extended healing times. Current research is limited by the 
lack of vascularized bone constructs. 
 This research provides a novel and promising approach to the vascularization 
of bone tissue engineered constructs. Here, stereolithographic printing is combined 
with both in silico modeling and in vitro testing to design and validate a biomimetic 
vascular architecture for use in TPS bioreactors. Under this system, cells can 
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experience the advantageous pre-aggregation flow and accompanying shear stress to 
preferentially differentiate down osteogenic pathways. Post aggregation, any number 
of these constructs could be combined either in series or in parallel, or both, to allow 
for the complete vascularization of even the largest of constructs.  
The first goal of this study was to examine the relationship between network 
porosity and oxygen concentration in an aggregated alginate construct within a 
tubular perfusion system bioreactor. This analysis was completed using COMSOL 
Multiphysics software, and resulted in a determination of a maximum center to center 
pore spacing of 3 mm. This spacing allows for the maintenance of at least 4% oxygen 
throughout a construct that utilizes the designed perfusion network, complete with 
750 μm diameter pores and air-saturated perfusion media. 
After determining the range of pore spacing which would result in relevant 
levels of oxygen throughout a construct, CAD network files were examined using 
computational fluid dynamics, via SolidWorks’ Flow Simulation package. It was 
determined that for the three tested designs, pre-aggregation flow was similar enough 
to expect the similar percentages of live cells in all constructs. Similarly, a uniform 
flow distribution was observed in all branches of the branched network designs. 
Further, the assumption that convection could be neglected in COMSOL simulations 
was validated. 
Finally, in silico modeling results from COMSOL and SolidWorks were 
examined in vitro by running a 48 hour bioreactor experiment complete with 
400,000,000 human bone-marrow derived mesenchymal stem cells and 5 
experimental groups. By performing viability assays after 24 hours of pre-aggregation 
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perfusion and again after 24 hours of post-aggregation perfusion, results were 
obtained that validated the in silico modeling. In short, Day 1 viability was not 
statistically different across all groups, while Day 2 viability displayed a trend of 
decreasing viability with decreasing network porosity. Furthermore, the potential 
efficacy of TPS bioreactor bone tissue engineered constructs as implants that can be 
utilized for direct anastomosis was demonstrated by perfusing fully aggregated 
constructs for the first time. 
The vascular network designed and printed here shows promise not only for 
use in TPS bioreactors, but also many other dynamic culture strategies. By combining 
this architecture with a biodegradable network material and a lining of endothelial 
cells, it may be possible to create a vascular network that provides for the extended 
growth and viability of hMSCs throughout an entire large scale construct. Further, the 
incorporation of large-diameter inlet and outlet channels allows for the potential 
direct anastomosis of these constructs to existing host vasculature. In conjunction 
with this, the major vascular axis featured in these constructs will allow for 
immediate perfusion upon implantation, while the network of pores will sustain cell 
life until the network can be fully integrated with the body via spontaneous host 
vascular ingrowth. 
In summary, a thorough combination of computer-aided design, in silico 
modeling, and in vitro experiments resulted in the development of a 3D printed 
network which provided adequate levels of oxygen throughout a BTE construct of 
more than 20 cm
3
, or twice the size of any current BTE constructs,
14
 to support the 
viability of human mesenchymal stem cells. Analysis of these results determined that 
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the overall hypothesis was validated by demonstrating that perfusion network design 
had no significant effect on the pre-aggregation viability of cells encapsulated within 
alginate beads, while post-aggregation viability was a function of oxygen 
concentration throughout the construct, and therefore porosity and distance of each 






Appendix A: Raw Data 
 
Table 1: 2% Alginate Bead Diameters in 0.1M CaCl2 
Bead Diameter 
(µm) 
3666.9 3313.8 3777.7 3847.7 3897.3 3675.2 3266.5 3042 3653.4 3335.6 















Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 111 16021 144.333 0.834 255 63.74327971 6.401433336
10x2 Live1.jpg 293 47106 160.771 2.453 255
10x3 Dead1.jpg 420 72694 173.081 3.786 255
10x3 Live1.jpg 567 98533 173.78 5.132 255
10x4 Dead1.jpg 234 31796 135.88 1.656 255
10x4 Live1.jpg 370 64213 173.549 3.344 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 96 15636 162.875 0.814 255 64.88481394 9.569068808
10x1 Live1.jpg 332 58160 175.181 3.029 255
10x2 Dead1.jpg 188 31415 167.101 1.636 255
10x2 Live1.jpg 315 52132 165.498 2.715 255
10x4 Dead1.jpg 291 40478 139.1 2.108 255
10x4 Live1.jpg 348 60088 172.667 3.13 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 194 34799 179.376 1.812 255 55.14460328 5.275484061
10x1 Live1.jpg 319 52741 165.332 2.747 255
10x2 Dead1.jpg 362 63204 174.597 3.292 255
10x2 Live1.jpg 421 79778 189.496 4.155 255
10x3 Dead1.jpg 342 67969 198.74 3.54 255
10x3 Live1.jpg 335 77140 230.269 4.018 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 160 22606 141.288 1.177 255 69.20765764 0.919683815
10x1 Live1.jpg 353 66461 188.275 3.462 255
10x3 Dead1.jpg 133 19853 149.271 1.034 255
10x3 Live1.jpg 287 59487 207.272 3.098 255
10x4 Dead1.jpg 111 18448 166.198 0.961 255
10x4 Live1.jpg 265 51976 196.136 2.707 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 298 33807 113.446 1.761 255 55.51329431 3.181738587
10x2 Live1.jpg 436 58852 134.982 3.065 255
10x3 Dead1.jpg 213 27360 128.451 1.425 255
10x3 Live1.jpg 266 39478 148.414 2.056 255
10x4 Dead1.jpg 527 86344 163.841 4.497 255



































Table 4: Bottom Inner Day 2 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 13 1455 111.923 0.076 255 71.62351096 24.36043006
10x1 Live1.jpg 257 53763 209.195 2.8 255
10x2 Dead1.jpg 309 62886 203.515 3.275 255
10x2 Live1.jpg 190 36233 190.7 1.887 255
10x3 Dead1.jpg 48 8213 171.104 0.428 255
10x3 Live1.jpg 213 46801 219.723 2.438 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 239 57393 240.138 2.989 255 40.64964562 11.60633773
10x1 Live1.jpg 232 45931 197.978 2.392 255
10x2 Dead1.jpg 133 17043 200.506 0.888 255
10x2 Live1.jpg 125 23721 199.336 1.235 255
10x3 Dead1.jpg 175 27343 156.246 1.424 255
10x3 Live1.jpg 56 7513 134.161 0.391 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 14 2916 208.286 0.152 255 85.18989578 8.452251065
10x1 Live1.jpg 171 31672 185.216 1.65 255
10x3 Dead1.jpg 48 6049 126.021 0.315 255
10x3 Live1.jpg 132 25565 193.674 1.332 255
10x4 Dead1.jpg 26 2386 91.769 0.124 255
10x4 Live1.jpg 229 48098 210.035 2.505 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 220 32950 149.773 1.716 255 45.79002086 5.836037845
10x1 Live1.jpg 210 47836 227.79 2.491 255
10x3 Dead1.jpg 63 7154 113.556 0.373 255
10x3 Live1.jpg 38 10825 284.868 0.564 255
10x4 Dead1.jpg 81 17525 216.358 0.913 255
10x4 Live1.jpg 84 12600 150 0.656 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 202 42074 208.287 2.191 255 60.42653982 0.603780249
10x1 Live1.jpg 299 58943 197.134 3.07 255
10x2 Dead1.jpg 134 27829 207.679 1.449 255
10x2 Live1.jpg 211 32173 152.479 1.676 255
10x4 Dead1.jpg 108 19729 182.676 1.028 255






























Table 5: Bottom Outer Day 1 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 247 42336 171.401 2.205 255 59.34731756 2.424091613
10x1 Live1.jpg 373 68290 183.083 3.557 255
10x3 Dead1.jpg 312 63062 202.122 3.284 255
10x3 Live1.jpg 398 73376 184.362 3.822 255
10x4 Dead1.jpg 226 35807 158.438 1.865 255
10x4 Live1.jpg 366 63255 172.828 3.295 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 252 33217 131.813 1.73 255 60.2816479 4.030766589
10x2 Live1.jpg 436 74176 170.128 3.863 255
10x3 Dead1.jpg 193 26654 138.104 1.388 255
10x3 Live1.jpg 327 52260 159.817 2.722 255
10x4 Dead1.jpg 193 22776 118.01 1.186 255
10x4 Live1.jpg 232 38789 167.194 2.02 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 249 53213 213.707 2.772 255 58.46653638 4.913987461
10x1 Live1.jpg 266 53277 200.289 2.775 255
10x3 Dead1.jpg 213 27361 128.455 1.425 255
10x3 Live1.jpg 329 57366 174.365 2.988 255
10x4 Dead1.jpg 177 23163 130.864 1.206 255
10x4 Live1.jpg 302 52882 175.106 2.754 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 255 47803 187.463 2.49 255 57.00716932 4.909690505
10x2 Live1.jpg 307 57713 187.99 3.006 255
10x3 Dead1.jpg 242 46763 193.236 2.436 255
10x3 Live1.jpg 268 53494 199.604 2.786 255
10x4 Dead1.jpg 141 24620 174.61 1.282 255
10x4 Live1.jpg 249 44509 178.751 2.318 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 298 33807 113.446 1.761 255 55.51329431 3.181738587
10x2 Live1.jpg 436 58852 134.982 3.065 255
10x3 Dead1.jpg 213 27360 128.451 1.425 255
10x3 Live1.jpg 266 39478 148.414 2.056 255
10x4 Dead1.jpg 527 86344 163.841 4.497 255
10x4 Live1.jpg 562 98644 175.523 5.138 255





































Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 81 19223 160.192 1.001 255 68.19791771 11.58596439
10x1 Live1.jpg 244 25749 130.045 1.341 255
10x2 Dead1.jpg 128 23697 185.133 1.234 255
10x2 Live1.jpg 138 27282 197.696 1.421 255
10x3 Dead1.jpg 53 5646 106.528 0.294 255
10x3 Live1.jpg 184 29411 159.842 1.532 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 110 21074 191.582 1.098 255 46.05070056 14.00955809
10x1 Live1.jpg 45 5521 122.689 0.288 255
10x2 Dead1.jpg 103 16713 162.262 0.87 255
10x2 Live1.jpg 178 40921 229.893 2.131 255
10x4 Dead1.jpg 77 15642 203.143 0.815 255
10x4 Live1.jpg 65 12062 185.569 0.628 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 10 1147 114.7 0.06 255 88.28978049 5.655029747
10x1 Live1.jpg 217 41690 192.12 2.171 255
10x2 Dead1.jpg 36 5605 155.694 0.292 255
10x2 Live1.jpg 162 31627 195.228 1.647 255
10x4 Dead1.jpg 36 3951 109.75 0.206 255
10x4 Live1.jpg 251 62196 247.793 3.239 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 102 21523 211.01 1.121 255 54.61697829 3.935265822
10x1 Live1.jpg 129 26061 202.023 1.357 255
10x3 Dead1.jpg 109 19412 178.092 1.011 255
10x3 Live1.jpg 106 21180 199.811 1.103 255
10x4 Dead1.jpg 102 15473 151.696 0.806 255
10x4 Live1.jpg 145 31227 215.359 1.626 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 202 42074 208.287 2.191 255 60.42653982 0.603780249
10x1 Live1.jpg 299 58943 197.134 3.07 255
10x2 Dead1.jpg 134 27829 207.679 1.449 255
10x2 Live1.jpg 211 32173 152.479 1.676 255
10x4 Dead1.jpg 108 19729 182.676 1.028 255
10x4 Live1.jpg 165 28388 172.048 1.479 255

































Table 7: Middle Inner Day 1 Raw Data 
 
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 319 50909 159.589 2.652 255 65.11923303 8.863297792
10x1 Live1.jpg 362 53111 146.715 2.766 255
10x3 Dead1.jpg 127 13423 105.693 0.699 255
10x3 Live1.jpg 368 59762 162.397 3.113 255
10x4 Dead1.jpg 81 11109 137.148 0.579 255
10x4 Live1.jpg 171 31024 181.427 1.616 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 196 27580 140.714 1.436 255 68.88178676 4.225521093
10x1 Live1.jpg 348 64574 185.557 3.363 255
10x2 Dead1.jpg 208 25824 124.154 1.345 255
10x2 Live1.jpg 450 85776 190.613 4.468 255
10x3 Dead1.jpg 108 13443 124.472 0.7 255
10x3 Live1.jpg 312 58551 187.663 3.05 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 216 38881 180.005 2.025 255 53.81283724 2.141837795
10x1 Live1.jpg 283 58798 207.767 3.062 255
10x3 Dead1.jpg 256 48530 189.57 2.528 255
10x3 Live1.jpg 273 57956 212.293 3.019 255
10x4 Dead1.jpg 218 45860 210.367 2.389 255
10x4 Live1.jpg 247 49572 200.696 2.582 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 248 40930 165.04 2.132 255 56.23345931 7.394431429
10x2 Live1.jpg 281 54621 194.381 2.845 255
10x3 Dead1.jpg 238 35898 150.832 1.87 255
10x3 Live1.jpg 230 45510 197.87 2.37 255
10x4 Dead1.jpg 194 28408 146.433 1.48 255
10x4 Live1.jpg 384 77219 201.091 4.022 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 298 33807 113.446 1.761 255 55.51329431 3.181738587
10x2 Live1.jpg 436 58852 134.982 3.065 255
10x3 Dead1.jpg 213 27360 128.451 1.425 255
10x3 Live1.jpg 266 39478 148.414 2.056 255
10x4 Dead1.jpg 527 86344 163.841 4.497 255
































Table 8: Middle Inner Day 2 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 90 15534 172.6 0.809 255 52.01150148 5.922366647
10x1 Live1.jpg 129 22734 176.233 1.184 255
10x2 Dead1.jpg 245 61063 249.237 3.18 255
10x2 Live1.jpg 196 50261 256.434 2.618 255
10x3 Dead1.jpg 229 38135 166.528 1.986 255
10x3 Live1.jpg 255 48907 191.792 2.547 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 149 17837 119.711 0.929 255 44.69950144 7.704445963
10x1 Live1.jpg 186 25013 134.478 1.303 255
10x2 Dead1.jpg 398 88439 222.209 4.606 255
10x2 Live1.jpg 246 45391 184.516 2.364 255
10x4 Dead1.jpg 316 48703 154.123 2.537 255
10x4 Live1.jpg 214 38940 181.963 2.028 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 102 20005 196.127 1.042 255 72.53821987 14.50873325
10x1 Live1.jpg 176 38998 221.58 2.031 255
10x2 Dead1.jpg 151 26572 175.974 1.384 255
10x2 Live1.jpg 239 44569 186.481 2.321 255
10x5 Dead1.jpg 21 3498 166.571 0.182 255
10x5 Live1.jpg 280 64725 231.161 3.371 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 143 17600 195.556 0.917 255 49.19596607 3.856926534
10x1 Live1.jpg 172 32531 219.804 1.694 255
10x2 Dead1.jpg 59 11535 195.508 0.601 255
10x2 Live1.jpg 50 14711 294.22 0.766 255
10x3 Dead1.jpg 229 24480 255 1.275 255
10x3 Live1.jpg 204 44845 262.251 2.336 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 368 73436 199.554 3.825 255 19.04019191 5.431124904
10x2 Live1.jpg 131 25186 192.26 1.312 255
10x3 Dead1.jpg 403 66281 164.469 3.452 255
10x3 Live1.jpg 61 9373 153.656 0.488 255
10x4 Dead1.jpg 195 30211 154.928 1.573 255


































Table 9: Middle Outer Day 1 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x3 Dead1.jpg 193 33948 175.896 1.768 255 58.43290253 3.636313546
10x3 Live1.jpg 254 40206 158.291 2.094 255
10x4 Dead1.jpg 236 33676 142.695 1.754 255
10x4 Live1.jpg 410 71400 174.146 3.719 255
10x5 Dead1.jpg 283 39343 139.021 2.049 255
10x5 Live1.jpg 346 57636 166.578 3.002 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 83 10966 132.12 0.571 255 65.13580999 2.289823931
10x2 Live1.jpg 161 24081 149.571 1.254 255
10x3 Dead1.jpg 130 19537 150.285 1.018 255
10x3 Live1.jpg 269 46266 171.993 2.41 255
10x4 Dead1.jpg 144 21687 150.604 1.13 255
10x4 Live1.jpg 235 38019 161.783 1.98 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 220 32661 148.459 1.701 255 58.60320054 3.675310142
10x2 Live1.jpg 338 66241 195.979 3.45 255
10x3 Dead1.jpg 364 43684 120.011 2.275 255
10x3 Live1.jpg 418 71648 171.407 3.732 255
10x4 Dead1.jpg 120 19031 158.592 0.991 255
10x4 Live1.jpg 194 32595 168.015 1.698 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 169 27114 160.438 1.412 255 62.01554293 1.198483492
10x1 Live1.jpg 295 55156 186.969 2.873 255
10x2 Dead1.jpg 142 21026 148.07 1.095 255
10x2 Live1.jpg 219 42612 194.575 2.219 255
10x3 Dead1.jpg 199 29671 149.101 1.545 255
10x3 Live1.jpg 322 57450 178.416 2.992 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 298 33807 113.446 1.761 255 55.51329431 3.181738587
10x2 Live1.jpg 436 58852 134.982 3.065 255
10x3 Dead1.jpg 213 27360 128.451 1.425 255
10x3 Live1.jpg 266 39478 148.414 2.056 255
10x4 Dead1.jpg 527 86344 163.841 4.497 255
































Table 10: Middle Outer Day 2 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 148 26929 181.953 1.403 255 59.3604882 3.706519039
10x1 Live1.jpg 221 36750 166.29 1.914 255
10x3 Dead1.jpg 131 23776 181.496 1.238 255
10x3 Live1.jpg 229 47639 208.031 2.481 255
10x4 Dead1.jpg 124 16999 137.089 0.885 255
10x4 Live1.jpg 149 25602 171.826 1.333 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 193 40785 211.321 2.124 255 42.26761454 4.240233978
10x1 Live1.jpg 133 19669 147.887 1.024 255
10x2 Dead1.jpg 232 39328 169.517 2.048 255
10x2 Live1.jpg 142 24560 172.958 1.279 255
10x3 Dead1.jpg 278 47874 172.209 2.493 255
10x3 Live1.jpg 257 49713 193.436 2.589 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 53 9452 178.34 0.492 255 68.37495076 10.81775697
10x1 Live1.jpg 189 42640 225.608 2.221 255
10x2 Dead1.jpg 256 59983 234.309 3.124 255
10x2 Live1.jpg 292 51897 177.729 2.703 255
10x3 Dead1.jpg 73 15315 209.795 0.798 255
10x3 Live1.jpg 205 38187 186.278 1.989 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 72 10740 149.167 0.559 255 63.86969723 3.928131234
10x1 Live1.jpg 163 46738 286.736 2.434 255
10x2 Dead1.jpg 95 21340 224.632 1.111 255
10x2 Live1.jpg 154 27338 177.519 1.424 255
10x3 Dead1.jpg 99 16941 171.121 0.882 255
10x3 Live1.jpg 151 29060 192.45 1.514 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 157 31393 199.955 1.635 255 47.78127468 0.527657703
10x1 Live1.jpg 143 25022 174.979 1.303 255
10x3 Dead1.jpg 132 24179 183.174 1.259 255
10x3 Live1.jpg 118 15034 127.407 0.783 255
10x4 Dead1.jpg 203 35054 172.68 1.826 255
































Table 11: Top Inner Day 1 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 247 44405 179.777 2.313 255 60.78250496 3.038131842
10x1 Live1.jpg 373 69476 186.263 3.619 255
10x2 Dead1.jpg 180 22935 127.417 1.195 255
10x2 Live1.jpg 331 66308 200.326 3.454 255
10x3 Dead1.jpg 204 41153 201.73 2.143 255
10x3 Live1.jpg 275 59717 217.153 3.11 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 132 16833 127.523 0.877 255 60.86678062 2.583858135
10x2 Live1.jpg 187 42307 226.241 2.203 255
10x3 Dead1.jpg 114 16549 145.167 0.862 255
10x3 Live1.jpg 207 44922 217.014 2.34 255
10x4 Dead1.jpg 160 29152 182.2 1.518 255
10x4 Live1.jpg 235 49339 209.953 2.57 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 141 19901 141.142 1.037 255 60.14698449 1.945218047
10x1 Live1.jpg 236 46288 196.136 2.411 255
10x2 Dead1.jpg 250 61758 247.032 3.217 255
10x2 Live1.jpg 343 59351 173.035 3.091 255
10x3 Dead1.jpg 170 30164 177.435 1.571 255
10x3 Live1.jpg 255 48246 189.2 2.513 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 151 28788 190.649 1.499 255 59.16169769 2.581575981
10x2 Live1.jpg 231 43785 189.545 2.28 255
10x3 Dead1.jpg 156 30752 197.128 1.602 255
10x3 Live1.jpg 195 35240 180.718 1.835 255
10x4 Dead1.jpg 185 30322 163.903 1.579 255
10x4 Live1.jpg 295 57027 193.312 2.97 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 298 33807 113.446 1.761 255 55.51329431 3.181738587
10x2 Live1.jpg 436 58852 134.982 3.065 255
10x3 Dead1.jpg 213 27360 128.451 1.425 255
10x3 Live1.jpg 266 39478 148.414 2.056 255
10x4 Dead1.jpg 527 86344 163.841 4.497 255
































Table 12: Top Inner Day 2 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 118 25208 213.627 1.313 255 61.57923368 5.226448878
10x1 Live1.jpg 188 38869 206.75 2.024 255
10x2 Dead1.jpg 77 13380 173.766 0.697 255
10x2 Live1.jpg 164 25866 157.72 1.347 255
10x3 Dead1.jpg 179 35428 197.922 1.845 255
10x3 Live1.jpg 221 50807 229.896 2.646 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 46 5409 117.587 0.282 255 76.24382952 3.640800487
10x1 Live1.jpg 198 47491 239.854 2.473 255
10x3 Dead1.jpg 41 5098 124.341 0.266 255
10x3 Live1.jpg 124 21825 176.008 1.137 255
10x4 Dead1.jpg 102 12750 125 0.664 255
10x4 Live1.jpg 268 55591 207.429 2.895 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 37 5250 141.892 0.273 255 81.46561665 1.831347192
10x1 Live1.jpg 193 38669 200.358 2.014 255
10x3 Dead1.jpg 50 7116 142.32 0.371 255
10x3 Live1.jpg 194 49026 252.711 2.553 255
10x4 Dead1.jpg 39 6220 159.487 0.324 255
10x4 Live1.jpg 166 34410 207.289 1.792 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 78 16150 207.051 0.841 255 55.65884194 9.382145132
10x1 Live1.jpg 147 32981 224.361 1.718 255
10x2 Dead1.jpg 81 13255 163.642 0.69 255
10x2 Live1.jpg 61 9333 153 0.486 255
10x3 Dead1.jpg 88 17884 203.227 0.931 255
10x3 Live1.jpg 125 34054 272.432 1.774 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 222 42040 189.369 2.19 255 41.71272943 4.681672898
10x1 Live1.jpg 184 29453 160.071 1.534 255
10x2 Dead1.jpg 293 56085 191.416 2.921 255
10x2 Live1.jpg 237 34907 147.287 1.818 255
10x4 Dead1.jpg 257 45520 177.121 2.371 255


































Table 13: Top Outer Day 1 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 126 23489 186.421 1.223 255 67.21615767 3.858991529
10x2 Live1.jpg 303 64478 212.799 3.358 255
10x3 Dead1.jpg 142 25949 182.739 1.352 255
10x3 Live1.jpg 319 67961 213.044 3.54 255
10x5 Dead1.jpg 197 38358 194.711 1.998 255
10x5 Live1.jpg 319 61840 193.856 3.221 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 258 41762 161.868 2.175 255 64.30342314 5.136341861
10x2 Live1.jpg 369 76570 207.507 3.988 255
10x3 Dead1.jpg 85 13211 155.424 0.688 255
10x3 Live1.jpg 210 41490 197.571 2.161 255
10x4 Dead1.jpg 212 30722 144.915 1.6 255
10x4 Live1.jpg 359 76281 212.482 3.973 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 227 29815 131.344 1.553 255 69.28495136 17.44056302
10x1 Live1.jpg 406 67842 167.099 3.533 255
10x2 Dead1.jpg 19 2410 126.842 0.126 255
10x2 Live1.jpg 243 40661 167.329 2.118 255
10x3 Dead1.jpg 304 52789 173.648 2.749 255
10x3 Live1.jpg 316 73190 231.614 3.812 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 193 36940 191.399 1.924 255 57.50172892 2.320376099
10x2 Live1.jpg 298 56541 189.735 2.945 255
10x3 Dead1.jpg 195 37806 193.877 1.969 255
10x3 Live1.jpg 254 55839 219.839 2.908 255
10x4 Dead1.jpg 286 40486 141.559 2.109 255
10x4 Live1.jpg 353 78323 221.878 4.079 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 298 33807 113.446 1.761 255 55.51329431 3.181738587
10x2 Live1.jpg 436 58852 134.982 3.065 255
10x3 Dead1.jpg 213 27360 128.451 1.425 255
10x3 Live1.jpg 266 39478 148.414 2.056 255
10x4 Dead1.jpg 527 86344 163.841 4.497 255
































Table 14: Top Outer Day 2 Raw Data 
 
  
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x2 Dead1.jpg 36 6359 176.639 0.331 255 77.58355065 13.3175751
10x2 Live1.jpg 206 38889 188.782 2.025 255
10x3 Dead1.jpg 167 24024 143.856 1.251 255
10x3 Live1.jpg 239 52811 220.967 2.751 255
10x4 Dead1.jpg 29 3359 115.828 0.175 255
10x4 Live1.jpg 229 55778 243.572 2.905 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 103 20629 200.282 1.074 255 63.63474053 1.452528909
10x1 Live1.jpg 189 46726 247.228 2.434 255
10x3 Dead1.jpg 68 10961 161.191 0.571 255
10x3 Live1.jpg 109 14344 131.596 0.747 255
10x4 Dead1.jpg 114 21155 185.57 1.102 255
10x4 Live1.jpg 208 45257 217.582 2.357 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 12 1306 108.833 0.068 255 81.82139036 8.557922769
10x1 Live1.jpg 183 36199 197.809 1.885 255
10x2 Dead1.jpg 72 10402 144.472 0.542 255
10x2 Live1.jpg 241 39518 163.975 2.058 255
10x4 Dead1.jpg 67 9223 137.657 0.48 255
10x4 Live1.jpg 197 42765 217.081 2.227 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 86 8318 96.721 0.433 255 60.00701192 8.452925339
10x1 Live1.jpg 212 54194 255.632 2.823 255
10x2 Dead1.jpg 147 24387 165.898 1.27 255
10x2 Live1.jpg 151 34278 227.007 1.785 255
10x3 Dead1.jpg 140 28539 203.85 1.486 255
10x3 Live1.jpg 195 46416 238.031 2.418 255
Slice Count Total Area Average Size %Area Mean Total Cells % Live AVG % Live STD DEV
10x1 Dead1.jpg 222 42040 189.369 2.19 255 41.71272943 4.681672898
10x1 Live1.jpg 184 29453 160.071 1.534 255
10x2 Dead1.jpg 293 56085 191.416 2.921 255
10x2 Live1.jpg 237 34907 147.287 1.818 255
10x4 Dead1.jpg 257 45520 177.121 2.371 255



































Appendix B: Calculations 
 
All equations were first solved by hand, and then transferred to the Engineering 


















Appendix C: ImageJ Macro Procedures 
 
ImageJ macros were written to allow for automated cell counting and image 
processing. This also ensured that all images were processed uniformly to prevent 
misrepresentation of data. These macros were then confirmed by hand-counting a few 
images to ensure that counts were accurate. Macros were created for each file by 
simply changing the file names to access corresponding images. Images were first 
processed, and then merged. Cell counts were obtained from individual live or dead 
images at 10x magnification. 
 
Figure 38: ImageJ Image Processing Macro 
 
 
Figure 39: ImageJ Image Overlay Macro 
 
 




Appendix D: Viability Analysis Graphical Results 
 
All results depicted here follow the legend as outlined in Figure 41. 
 
Figure 41: Legend for All Viability Graphs 
 
Figure 42: Day 1 Viability Results 






               Figure 43: Day 2 Viability Results 
In Figure 43, groups that do not share a letter are statistically different.  
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Appendix E: COMSOL Simulation Results 
 
Figure 44: 1.5 mm Pore Spacing - Middle Branch, FEP 
 




Figure 46: 3 mm Pore Spacing - Middle Branch, FEP 
 




Figure 48: 9 mm Pore Spacing - Middle Branch, FEP 
 




Figure 50: 1.5 mm Pore Spacing – Top/Bottom Branch, FEP 
 




Figure 52: 3 mm Pore Spacing – Top/Bottom Branch, FEP 
 




Figure 54: 9 mm Pore Spacing – Top/Bottom Branch, FEP 
 




Figure 56: 1.5 mm Pore Spacing – Singe Tube, FEP 
 




Appendix F: SolidWorks CFD Results 
 
All CFD results adhere to the legend set forth in Figure 58, unless otherwise stated. 
 
 









Figure 60: Close Pore Vertical Cut Plot, 5 mm Offset 
 
 





Figure 62: Close Pore Horizontal Cut Plot 
 
 




Figure 64: Distant Pore Vertical Cut Plot, 5 mm Offset 
 
 




Figure 66: Distant Pore Horizontal Cut Plot 
 
 




Figure 68: Single Tube Vertical Cut Plot, 5 mm Offset 
 




Figure 70: CFD Legend for Darcy Flow Simulations 
 
 
Figure 71: Darcy Trajectory Profile, Close Pore Group 
 




Figure 73: Darcy Trajectory Profile Side View 
 
 
Figure 74: Darcy Horizontal Cut Plot, Pore Gradient Profile 






Figure 77: Day 2 Construct, Distant Pore Group 
Figure 75: Day 2 Construct Extraction from 
Silicone Group 





Figure 78: Trimmed Construct Demonstrates Complete Bead Infiltration 
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